UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
___________
FORM 20-F
[ ] REGISTRATION STATEMENT PURSUANT TO
SECTION 12(b) OR (g) OF
THE SECURITIES EXCHANGE ACT OF 1934
or
[x] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)
OF
THE SECURITIES EXCHANGE ACT OF 1934
or
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Commission File No. 0-26005
___________
MICROMEM TECHNOLOGIES INC
.
777 Bay Street, Suite 1910,
Toronto, Ontario M5G 2E4, Canada
Tel: (416) 364-6513
Fax: (416) 360-4034
Securities registered or to be registered pursuant to Section 12(b) of the Act:
None
Securities registered or to be registered pursuant to Section 12(g) of the Act:
Common Shares
Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act:
None
Indicate the number of outstanding shares of each of the issuer's classes of capital or common stock as of the close of the period covered by the annual report
46,700,937 Common Shares
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days:
Yes X No
Indicate by check mark which financial statement item the Registrant has elected to follow:
Item 17 X Item 18
TABLE OF CONTENTS
Part I
Page |
||
Item 1. |
Identity of Directors, Senior Management and Advisors |
1 |
Item 2. |
Offer Statistics and Expected Timetable |
1 |
Item 3. |
Key Information |
1 |
Item 4. |
Information on the Company |
6 |
Item 5. |
Operating and Financial Review and Prospects |
16 |
Item 6. |
Directors, Senior Management and Employees |
20 |
Item 7. |
Major Shareholders and Related Party Transactions |
24 |
Item 8. |
Financial Information |
25 |
Item 9. |
The Offer and Listing |
25 |
Item 10. |
Additional Information |
26 |
Item 11. |
Quantitative and Qualitative Disclosures about Market Risk |
33 |
Item 12. |
Description of Securities Other Than Equity Securities |
33 |
Part II
Item 13. |
Defaults, Dividend Arrearages and Delinquencies | 33 |
Item 14. |
Rights of Security Holders and Use of Proceeds |
33 |
Item 15. |
Controls and Procedures |
33 |
Part III
Item 17. |
Financial Statements |
34 |
Item 18. |
Financial Statements |
65 |
Item 19. |
Exhibits |
65 |
Signatures |
66 |
PART I
INTRODUCTION
Abbreviations
Reference throughout this document to Micromem Technologies Inc. and/or its affiliates may be made through abbreviated forms of their respective names. See "Item 4. Information on the Company - C. Organizational Structure" for a summary of these abbreviated names.
Forward Looking and Cautionary Statements
This Form 20-F contains certain forward-looking statements. These forward-looking statements are based on current expectations, estimates and projections about the business of the Company and the industry in which the Company operates, management's beliefs, and assumptions made by management. Words such as "expects," "anticipates," "intends," "plans," "believes," "seeks" and "estimates," variations on such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions which are difficult to predict. The Company's actual results could differ materially from those expressed or forecasted in these forward-looking statements as a result of certain factors, including those set forth under "Description of Business" and elsewhere in this Form 20-F.
ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISORS
Not Applicable
ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE
ITEM 3. KEY INFORMATION
A. Selected Financial Data
Selected balance sheet information
Years ended October 31, |
||||||||||
2002 |
2001 |
2000 |
1999 |
1998 |
||||||
Working capital (deficiency) |
$ |
985,551 |
$ |
3,455,108 |
$ |
1,076,127 |
$ |
(317,3096) |
$ |
(516,425) |
Capital Assets |
98,654 |
336,839 |
381,125 |
55,097 |
15,334 |
|||||
Total Assets |
1,583,422 |
14,454,470 |
2,219,987 |
585,327 |
164,020 |
|||||
Shareholder's equity (deficiency) |
1,391,903 |
14,124,918 |
1,684,775 |
(3,095,695) |
(500,991) |
Selected statement of operations and deficit information
|
Years ended October 31, |
||||
|
2002 |
2001 |
2000 |
1999 |
1998 |
Interest & other income |
$ (165,892) |
$ (196,520) |
$ (140,231) |
$ (1,303) |
$ (2,571) |
Research and development |
1,601,624 |
2,212,679 |
1,205,777 |
455,288 |
50,000 |
General and administrative expenses |
|
|
|
|
|
Write-down of royalty rights |
10,000,000 |
- |
- |
- |
- |
Loss before income taxes |
12,768,552 |
4,529,411 |
7,234,356 |
5,207,787 |
499,742 |
Provision for income taxes (recovery) |
(35,537) |
30,214 |
25,000 |
- |
- |
Net loss |
12,733,015 |
4,559,625 |
7,259,356 |
5,207,787 |
499,742 |
Loss per share-basic & diluted |
0.27 |
0.10 |
0.19 |
0.14 |
0.02 |
Weighted average number of basic and diluted shares |
|
|
|
|
|
Reconciliation between Canadian GAAP and U.S. GAAP:
The Company's consolidated financial statements have been prepared in accordance with Canadian GAAP which, in the case of the Company, conform in all material respects with U.S. GAAP, except for those items disclosed in note 17 to the notes to the Consolidated Financial Statements.
Currency and Exchange Rates
The financial statements of the Company are all expressed in United States dollars. All other financial data appearing in this Form 20-F are expressed in United States dollars ("US $"), with the exception of certain limited cases when reference is made to instruments denominated in Canadian dollars ("CDN $").
Transactions that were conducted in Canadian dollars or other foreign currencies have been converted into United States dollars at the rate of exchange prevailing at the date of such transactions, and assets and liabilities denominated in Canadian dollars or other foreign currencies but expressed in this Form 20-F in United States dollars have been converted into United States dollars at the rate of exchange prevailing on the date of the applicable financial statement.
The following table sets forth, for the periods indicated, the high, low, end of period and average for period noon buying rates as published by the Bank of Canada (the "Noon Buying Rate"), as expressed in the amount of U.S. Dollars equal to one Canadian dollar.
The following table sets forth, for each period indicated, the high and low exchange rates for United States dollars expressed in Canadian dollars on the last day of each month during such period, based on the Noon Buying Rate.
February 2003 |
January 2003 |
December 2002 |
November 2002 |
October 2002 |
September 2002 |
|
High |
1.4950 |
1.5340 |
1.5801 |
1.5713 |
1.5696 |
1.5879 |
Low |
1.4832 |
1.5203 |
1.5768 |
1.5632 |
1.5555 |
1.5753 |
On March 3, 2003, the noon buying rate for one Canadian dollar as quoted by the Bank of Canada was US $0.6736 (US $1.00 = CDN $1.4846).
B. Capitalization and Indebtedness
Not Applicable.
C. Reasons for the Offer and Use of Proceeds
Not Applicable.
D. Risk Factors
The Company and the Company's investors face a number of significant risks, which are described below.
Going Concern
There is substantial doubt about the Company's ability to continue as a going concern because of the substantial losses incurred in the development state. In addition the Company is still in the development state and it will be necessary to raise additional funds for the continuing development, testing and commercial exploitation of its technologies. The sources of these funds have not yet been identified and there can be no certainty that sources will be available in the future. As such, the realization of the Company's assets and discharge of its liabilities is subject to significant uncertainty.
The Company's ability to continue as a going concern is dependent upon completing the development of its technology for a particular application, achieving profitable operations, obtaining additional financing and successfully bringing its technologies to the market. The outcome of these matters cannot be predicted at this time. The consolidated financial statements have been prepared on a going concern basis and do not include any adjustments to the amounts and classifications of the assets and liabilities that might be necessary should the Company be unable to continue in business.
The Company Currently Has No Operating Revenue
The Company has no revenues and it does not expect to generate revenues in the near future. If the Company fails to enter into any license agreements it will have no revenues and even if it enters into such agreements the amount of the revenues it receives will depend on the terms it is able to get from each licensee and the ability of each licensee to compete in its particular market.
The Company's Technology is under Development
The Company's technology is currently under development and is therefore not yet proven to be commercially viable. In order that the Company may be able to procure revenue generating licensing arrangements, significant development work remains to be completed.
Products Using the Technology Have Not Yet Been Manufactured
The Company's success depends on whether its technology can be manufactured in large quantities at competitive prices. Failure to be able to manufacture large quantities at competitive prices will seriously hurt the Company's ability to generate revenues.
Competitors are seeking to develop Other Magnetic based Memory Technologies
Most of the major producers of memory components and devices are reported to be conducting research directed towards the development of other non-volatile random access memory technologies. While information concerning such research is difficult to obtain, reports indicate that very large sums of money are being spent and that major companies such as IBM, Motorola and Honeywell, that have enormous resources at their disposal, are involved.
Failure To Receive Continued Financing Will Cause the Business to Suffer
Since the Company expects no revenues in the near future, the Company will need additional financing to continue the research and development and to successfully market the technology to potential licensees. While the Company has had sufficient funds thus far to meet its requirements, there is no assurance it will be able to continue to do so, and failure to raise sufficient funds in the future will affect its ability to develop and market the technology.
Because Much of the Company's Success and Value Depends On Its Ownership and Use of Intellectual Property the Company's Failure to Protect That Property Could Adversely Affect Its Future Growth and Success |
The Company's success will depend on its ability to protect its intellectual property. The Company relies primarily on patent, copyright, trademark and trade secret laws, as well as nondisclosure agreements and other methods to protect its proprietary technologies and processes. Despite its efforts to protect its proprietary technologies and processes, unauthorized parties may attempt to copy or otherwise obtain and use its products or technology without authorization, develop similar technology independently or design around its patents. Policing unauthorized use of the Company's products is expensive and difficult, and the Company cannot be certain that the steps it has taken will prevent misappropriation or infringement of its intellectual property.
Intellectual Property Claims Against the Company, No Matter How Groundless, Could Cause Its Business To Suffer |
The Company's future success and competitive position depend in part on its ability to retain exclusive rights to its technology, including any improvements that may be made on that technology from time to time by the Company or on its behalf. While the technology is patented or subject to pending patent applications in the U.S.A. and the Company knows of no challenge that has been made either against the technology or against the Company's rights to it, and has no reason to believe that any such challenge might be made or that the grounds for any such challenge exist, if any intellectual property litigation were to be commenced against the Company, no matter how groundless, the result would be significant expense, adversely affecting further development, licensing and sales, and diverting the efforts of its technical and management personnel and, in the event of an adverse outcome, substantial damages and possible restrictions on the further development licensing and use of the technology.
There is no assurance that any of the pending applications will be issued as patents or that any issued patent will not be determined to be invalid at a later date.
No Foreseeable Dividends
Micromem has never paid a dividend on its securities. Micromem does not anticipate paying dividends in the foreseeable future.
Issuance of Additional Securities and Dilution
The board of directors of Micromem has the authority to issue additional Common Shares or other securities of Micromem without the prior consent or vote of Micromem's shareholders. The issuance of additional Common Shares may have the effect of diluting the proportionate equity interest and voting power of holders of Shares.
Dependence on Key Personnel
The Company's success will depend on its ability to retain certain of its senior management and key technical personnel. It will also depend, to a large extent, on its ability to attract and retain additional highly skilled personnel in the future.
The Company may be materially affected by global economic and political conditions
The Company's ability to generate revenue may be adversely affected by the slowdown in the global economy as companies delayed their purchase decisions, reduced their technology spending budgets, increased their purchase authorization approval requirements, and reduced their capital expenditures by maximizing the current capacities of their data storage equipment. The Company does not currently anticipate any significant improvement in technology spending during 2003. During 2002, the Company implemented various cost-saving measures to help mitigate the adverse effects of the slowdown in the global economy. The Company cannot provide any assurance that a prolonged economic downturn will not have additional adverse effects on the Company's financial condition, results of operations, or our ability to generate revenue growth. Furthermore, the Company cannot provide any assurance that our cost-saving measures will be successful or sufficient to allow the Company to continue to generate improved operating results in future periods.
The Company's financial condition and results of operations could also be materially affected by unstable global political conditions. Terrorist attacks or acts of war could significantly disrupt the Company's operations and the operations of the Company's future customers, suppliers, distributors, or resellers. The Company cannot predict the potential impact on its financial condition or results of operations should such events occur.
The Company may be materially affected by aggressive competition
The memory and data storage industry is highly competitive, and customers make their decisions based on a number of competitive factors, including the following:
• Functionality
•Technology
•Performance
• Reliability
•System scalability
•Price
• Quality
• Product availability
• Customer service
•Brand recognition
The Company must address each of these factors effectively in order to successfully compete. If the Company is unable to adapt its products and services to changes in these competitive factors, it may never gain market share.
The Company may be materially affected by rapid technological change and evolving industry standards
Short product life cycles are inherent in high-technology industries due to rapid technological change and evolving industry standards. The Company's future financial condition and results of operations depend on its ability to respond effectively to these changes. The Company cannot provide any assurance that it will be able to successfully develop, manufacture, and market innovative new products or adapt its current products to new technologies or new industry standards. In addition, customers may be reluctant to adopt new technologies and standards, or they may prefer competing technologies and standards. Because the technology market changes so rapidly it is difficult to predict the rate adoption of its ferromagnetic memory technology.
The Company may be materially affected by risks associated with new product development
New product research and development is complex and requires the investigation and evaluation of multiple alternatives, as well as planning the design and manufacture of those alternatives selected for further development. Research and development efforts could be adversely affected by any of the following:
• Hardware and software design flaws
• Product development delays
• Changes in data storage technology
• Changes in operating systems
• Changes in industry standards
Manufacturing new products involves integrating complex designs and processes, coordinating with suppliers for parts and components, and managing manufacturing capacities to accommodate forecasted demand. Failure to obtain sufficient quantities of parts and components, as well as other manufacturing delays or constraints, could adversely affect the timing of new product introductions. The Company has experienced product development delays in the past that adversely affected its financial position.
The Company may be materially affected by the risks associated with developing and protecting intellectual property
The Company depends on its ability to develop new intellectual property that does not infringe on the rights of others. The Company cannot provide any assurance that it will be able to continue to develop such new intellectual property.
The Company relies on a combination of U.S. patent, copyright, trademark, and trade secret laws to protect its intellectual property rights. The Company enters into confidentiality agreements relating to its intellectual property with its employees and consultants.
Due to financial constraints, the Company has determined not to file patent and trademark registration applications with foreign governments; this may expose us and our technologies to infringement in foreign jurisdictions.
Despite all of the Company's efforts to protect its intellectual property rights, unauthorized parties may attempt to copy or otherwise obtain or use its intellectual property. Monitoring the unauthorized use of the Company's intellectual property is difficult, particularly in foreign countries. The Company cannot provide any assurance that it will be able to adequately protect its intellectual property.
The Company may be materially affected if it is unable to attract, retain, and motivate key employees
The Company's future success depends in large part on its ability to attract, retain, and motivate its key employees. The Company faces significant competition for individuals who possess the skills required to design, develop, manufacture, and market the Company's technologies. An inability to successfully attract, retain, and motivate these employees in the future could have an adverse effect on the Company's future financial condition and results of operations.
Volatility of Common Share Price and Volume
Shareholders of Micromem may be unable to sell significant numbers of common shares of Micromem on the NASD OTC-BB (where the common shares are currently traded) without a significant reduction in the price of the shares, if at all.
Furthermore, there can be no assurance that the Company will be able to meet the listing requirements of, or achieve listing on, any other stock exchange. The market price of the common shares of the Company may be affected significantly by factors such as fluctuations in the Company's operating results, announcements of technological innovations or new products by the Company or its competitors, action by governmental agencies against the Company or the industry in general, developments with respect to patents or proprietary rights, public concern as to the safety of products developed by the Company or others, the interest of investors, traders and others in public companies such as the Company and general market conditions. In recent years, the securities markets in the United States and Canada have experienced a high level of price and volume volatility, and the market price of securities of many companies, particularly small capitalization companies, have experienced fluctuations which have not necessarily been related to the operating performances, underlying asset values or prospects of such companies.
ITEM 4. INFORMATION ON THE COMPANY
A. History and Development of the Company
Purchase of Pageant Technologies Incorporated
On January 11, 1999, Micromem completed the acquisition of 100% of the capital stock of Pageant International, in exchange for 32,000,000 Common Shares and warrants for the purchase of an additional 1,000,000 Common Shares (the "Warrants"), representing 88.94% of the outstanding Common Shares of Micromem (89.24% assuming exercise of all the Warrants). The acquisition was completed pursuant to an agreement, dated December 7, 1998, among Micromem, as the purchaser, and Ataraxia Corp., as the vendor, and Pageant International. The Warrants were exercisable at CDN $2.00 per share through January 11, 2000 and thereafter at CDN $2.30 per share through January 12, 2001 on which date the Warrants remaining unexercised expired. The total purchase price for the Pageant International Common Stock was $30,000,000. The value of the Common Shares used to pay the purchase price was determined through arm's length negotiations using as a point of reference the price per Common Share of $1.16 on September 23, 1998 less an agreed upon discount.
The primary asset of Pageant International was an undivided 50% interest in patents, issued in the United States and Europe, with a corresponding application in Japan, for nonvolatile random access memory technology which was, at the time, called MAGRAM and which is, today, called VEMRAM™ 1 (the "VEMRAM™ Patents"). The VEMRAM™ technology also includes certain improvements to the VEMRAM™ Patents, many of which are the subject of pending patent applications. The undivided 50% interest in the VEMRAM™ Patents was originally conveyed to Ataraxia Corp. by Estancia Limited, a company incorporated under the laws of the Turks & Caicos Islands ("Estancia" ) , pursuant to a Joint Ownership and Licensing Agreement dated September 17, 1997 (the "Joint Ownership and Licensing Agreement") which Ataraxia Corp. assigned to Pageant International on October 22, 1997 with the written consent of Estancia. In addition to the undivided 50% interest in the VEMRAM™ Patents, under the Joint Ownership and Licensing Agreement Pageant International was granted an exclusive worldwide license to develop, manufacture and sell the VEMRAM™technology. The Joint Ownership and Licensing Agreement requires Pageant International to pay Estancia or its nominee a royalty of 40% of the gross profits less expenses agreed by the parties for each technology license sold. Additionally, Pageant International would be required to pay Estancia Limited 40% of any per unit royalty received by Pageant less properly documented reasonable expenses directly related to the obtaining of those royalties and as agreed by the parties in writing.
___________________________
1
VEMRAM™ is a trade-mark of Memtech International Inc., a Bahamas
corporation wholly-owned by Micromem, and is used under license by Micromem and
other corporations affiliated with Micromem.
The Joint Ownership and Licensing Agreement also provided that if Pageant International, as approved assignee of Ataraxia Corp., sold the rights to the VEMRAM™ technology to a third party not owned or controlled by it, it would have to pay Estancia 50% of the proceeds from such transaction. This provision makes it clear that in the event of the sale of all of the VEMRAM™ technology rights, 50% of the proceeds would go to Estancia, reflecting its 50% undivided interest in the technology, rather than 40% reflecting its royalty rights under the VEMRAM™ License. Estancia is controlled by John Zammit. Mr. Zammit has no direct control relationship with Micromem, and the management of Micromem is not aware that Mr. Zammit has any indirect control relationship with Micromem or any control relationship, direct or indirect, with Ataraxia Corp.
See "Item 4. Information on the Company – B. Business Overview - Recent Developments – Agreement to Purchase Estancia Interests".
The acquisition of Pageant International was treated as a reverse takeover for accounting purposes. A reverse takeover is deemed to have occurred when a company uses so much of its voting stock to purchase another company that the former stockholders of the acquired company could be said to have ended up controlling the company doing the acquiring. In the case of the purchase of Pageant International by Micromem, the two former shareholders of Pageant International ended up with a greater number of voting shares than did the pre-acquisition Micromem shareholders and therefore have been deemed to have apparent control. The consolidated financial statements of Micromem are presented as a continuation of the financial position and results of Pageant International, even though Micromem remains the legal parent and Pageant International remains the legal subsidiary. The primary consequence of the application of this treatment to the acquisition is that the patent rights are recorded at $100, the historical value at which they were carried on the Pageant International balance sheet, rather than being increased to reflect a significantly greater valuation.
Changes to Board of Directors and Management
On January 11, 1999, immediately following the acquisition, Stephen Fleming, who had been serving as President and Chief Executive Officer of Pageant USA, was elected to Micromem's Board to join Salvatore Fuda and Ross McGroarty, who had served as directors since 1992 and 1988, respectively. The Board then elected Mr. Fuda as Chairman, Mr. Fleming as President and Chief Executive Officer, and Mr. McGroarty, who had been serving as President, as Executive Vice President and Secretary of Micromem. Subsequently, on March 18, 1999, Robert Patterson, who had been serving as Chairman of the Board and Vice President of Corporate Development of Pageant USA, was elected President and Chief Executive Officer of Micromem to replace Mr. Fleming. On November 15, 1999, Antonio Lopes was appointed Chief Financial Officer of Micromem. On June 15, 2000, Mr. McGroarty resigned as Executive Vice-President of Micromem.
At the annual meeting of shareholders of Micromem held on June 29, 2000, the following individuals were elected as directors of Micromem: Andrew Brandt, Stephen Fleming, Salvatore Fuda, Charles Harnick and George Kennedy. The terms of all previously elected directors ended on such date. The term of Mr. Lopes' employment as Micromem's Chief Financial Officer having ended on June 5, 2000, Raj Viswanathan was appointed as Chief Financial Officer. The term of Robert Patterson's employment as Micromem's President and Chief Executive Officer having ended, Salvatore Fuda was reappointed as Chairman and he was appointed as Chief Executive Officer on June 29, 2000. Also on June 29, 2000, Manoj Pundit was appointed as Executive Vice-President and General Counsel of Micromem. On February 21, 2001, Dr. Dale Hensley was appointed as Chief Operating Officer of Micromem and Pageant USA.
At the annual meeting of shareholders of Micromem held on March 14, 2001, Andrew Brandt, Stephen Fleming, Salvatore Fuda, Charles Harnick, George Kennedy, Manoj Pundit and David Sharpless were elected as directors of Micromem.
At a meeting of the Board of Directors held on March 14, 2001, a resolution was passed appointing Dale Hensley as a director of Micromem. At a meeting of the Board of Directors held on February 13, 2002, the Board accepted the resignation of Salvatore Fuda as President and Chief Executive Officer of Micromem due to health reasons. Salvatore Fuda continues to serve as Chairman and Director of Micromem. In his place, the Board appointed Joseph Fuda to serve as President and Chief Executive Officer. Mr. J. Fuda was also appointed as a director. Messrs. Andrew Brandt, Stephen Fleming, Salvatore Fuda, Charles Harnick, Dale Hensley, George Kennedy, Manoj Pundit, David Sharpless and Stephen Van Fleet were elected as directors of Micromem at the annual meeting held April 30, 2002.
Dr. Dale Hensley's employment as Chief Operating Officer was terminated by Micromem and by Pageant USA effective as of September 24, 2002. Raj Viswanathan resigned as Chief Financial Officer of Micromem on October 31, 2002 and as a director of Pageant USA on September 26, 2002. Dr. Hensley resigned as a director of Pageant USA on September 26, 2002 and as a director of Micromem effective October 9, 2002. Antonio Lopes was appointed as Chief Financial Officer of Micromem with effect from November 1, 2002. Messrs. Salvatore Fuda, Joseph Fuda, Manoj Pundit and Antonio Lopes continue to hold their respective offices, as described above, at the date of this Form 20F.
B. Business Overview
The Company is engaged in the development of memory technologies having the characteristic of non-volatility, which is the ability to retain information after power has been shut off.
The Company's Technology (as defined in the next paragraph below) is based on ferromagnetism, which consists of microscopic magnetic elements and Hall effect sensors deposited on a substrate of silicon or glass. Each magnetic element stores one bit of data based on its ability to alternate between states of magnetic polarization, which states are determined by a Hall effect sensor normal to the magnetic field. The Company's Technology represents "1"s and "0"s by the different polarization of magnets; for example, a magnet oriented north/south is a "1" and a magnet oriented south/north is a "0". The magnetic field strength and direction do not decay when power is switched off; therefore, the memory is non-volatile.
Micromem has been pursuing the development of its two unique memory technologies (collectively, the "Company's Technology"): (i) a memory design with the magnetic bit aligned horizontally to the substrate (known as "HEMRAM™ 2 "); and (ii) a memory design with the magnetic bit aligned vertically to the substrate ("VEMRAM™ "). During the 2002 fiscal year, Micromem's Chief Operating Officer oversaw an R&D team focused on the further development of the thin film horizontal element magnetic devices and applications of this technology. The inventor under the patent for the VEMRAM™ technology has been contracted to assist Pageant USA in the development of the vertical element magnetic technology. The Company has a portfolio of patents and patent applications protecting the technologies that it is developing.
_______________________
2 HEMRAM™ is a trade-mark of Memtech International Inc., a Bahamas corporation wholly-owned by Micromem, used under license by Micromem and other corporations affiliated with Micromem.
Industry Background
The semiconductor memory industry is principally driven by the requirements of the computing industry. The nature of the memory manufacturing industry is that it is capital intensive, cyclical, rapidly changing and depends significantly on patent protection.
The semiconductor industry is intensely competitive. Both low-density and high-density nonvolatile memory products are manufactured and marketed by major corporations possessing worldwide wafer manufacturing and integrated circuit production facilities and by specialized product companies.
Company's Technology
The various characteristics of the Company's Technology can be better understood by describing the three basic types of memory used by present day computers, Random Access Memory (RAM), Read Only Memory (ROM), and secondary storage devices such as floppy and hard disks. The three types of memory are described below:
Random Access Memory (RAM) is memory that can be both read and written randomly, which means that its storage locations can be accessed in any order. Thus a computer using RAM can find and go directly to the selected location rather than performing a sequential search. Semiconductor RAM is usually the primary memory associated with the computer's central processing unit (CPU) , the computational unit of the computer responsible for interpreting and executing instructions. However, RAM is volatile which means that all stored information vanishes once the power supply is removed and must be restored from a secondary storage device each time the power is resumed.
Two typical examples of RAM are Dynamic Random Access Memory and Static Random Access Memory. Dynamic Random Access Memory (DRAM) uses integrated circuits containing capacitors to achieve significant storage capacity and speed. DRAM can be written and read in the speed range of less than 100 nanoseconds. DRAM has a major drawback in that its capacitors lose their charge over time and therefore information contained in DRAM must be continually refreshed. Basically, this means that on average DRAM must stop operations every 16-30 milliseconds and restore all of the data it contains or the data will disappear. During this refresh time, the processor has no access to the information being refreshed. Static Random Access Memory (SRAM) differs from DRAM in that it stores information in a logic circuit referred to as a flip-flop, rather than in a capacitor. SRAM memory does not need to be refreshed while the power is on, but also loses its information once the power is turned off.
Read Only Memory (ROM ) , like RAM, can be read randomly, but cannot be written randomly. Unlike RAM, however, it is non-volatile and therefore does not lose its information when a computer's power is cut off. ROM is typically employed to store vital program information required during the first moments after a computer is powered on. It may be used for such purposes as forcing system test routines, directing the processor to input/output devices or for controlling access to certain computer subsystems such as hard drives. EPROMs (erasable programmable read-only memory) and EEPROMs (electrically erasable read-only memory) are read only memories that can be erased and rewritten, but must be written "en masse," rather than at the individual word level. "Flash" memory is a form of EEPROM that is widely used today in such devices as cell phones, modems and personal digital assistants. The drawbacks to Flash memory are that write times are slower, the number of read/write cycles are limited and the requirement for significantly higher power than DRAM to store data.
Secondary Storage Devices include Floppy Disks, which are light and portable and are written and read by a motor driven mechanical drive. They normally have a storage capacity in the low megabyte range. Hard Disks far exceed floppy disks in storage capacity and have become the standard for mass storage of data to be written and read by the processor. Both Floppy Disks and Hard Disks are non-volatile and can be both written and read. However, since they are serial (as opposed to parallel) devices, they are considerably slower than RAM.
Micromem's horizontal element magnetic memory technology, HEMRAM™ , involves producing hybrid memories based on in-plane magnetization mechanism of horizontally oriented micron scale ferromagnetic thin films that act as storage elements. An in-plane magnetization generates a spatially inhomogeneous field profile with a narrow fringe field normal to the substrate. This fringe field results in a measurable Hall voltage across the probe terminals when a current flows through the sensor. Changing current direction will lead to a reversed Hall voltage. This intrinsically bipolar output forms the basis of nonvolatile storage, logic gate and field sensing.
Micromem's vertical element magnetic memory technology, VEMRAM™, uses a novel hybrid Hall effect MRAM scheme which utilizes out-of-plane magnetization induced by vertically oriented high-aspect-ratio ferromagnetic posts. The VEMRAM™ cell comprises two parts: a high-aspect-ratio ferromagnetic storage post or "bit" (memory element) and a patterned high-mobility thin film Hall sensing element (InAs or InSb) underneath the bit. The bit is vertically positioned or normal to the probe surface, which is necessary to suppress so-called "N" rotation, a tendency for the magnetic field in a ferromagnet to rotate away from its set direction under the influence of an external perturbing magnetic field. The memory bits and driving circuits can be directly constructed on a wafer where Hall sensors have already been produced by direct implantation or by epitaxial growth and patterned etching. In the writing operation, each bit is coerced to change its magnetic states by the drive current flowing along the surrounding single-turn electrical loop. When the drive current is reversed, the remnant state switches from one state to the other to store a new binary number. The reading process remains essentially the same as in the in-plane magnetization arrangement.
Competition
The Company is aware of others conducting research and development in the magnetic non-volatile memory area. These include IBM Research (San Jose, California), Ovonyx, Inc. (Troy, Michigan), Hewlett-Packard (Palo Alto, California), Honeywell (Plymouth, Minnesota) and Motorola (Phoenix, Arizona).
In February 2002, Cypress Semiconductor Corp. formed a subsidiary to develop magnetic RAM in association with NVE and has allocated $22 million in research and development to bring a product to market.
The basic MRAM cell consists of one transistor and one magnetic tunneling junction. Reading the cell involves passing a current through the magnetic tunneling junction (MTJ) stack. Two main centers of MRAM research are at IBM and Infineon. IBM and Infineon have alternative MRAM technologies based on the giant magneto resistance (GMR) principle. GMR memory elements consist of two ferromagnetic layers separated by a conductive nonmagnetic interlayer. The electrical resistance is high in the absence of external magnetic field; however, an applied external field forces the initially anti-parallel magnetization in the coupled films into parallel alignment and the resistance drops. The high or low resistance determines the data storage state. MTJ cells have similar sandwiched structures but the interlayer is insulating instead of conducting. In contrast to GMR structures in which the sense current usually flows parallel to the layers, the current in MTJ flows perpendicularly to the layers of the stack.
Neither the current stages of development of these companies' non-volatile technologies nor their projected development completion dates are known.
Micromem's technology is based on a variety of realizations of low-cost hybrid Hall effect magnetic cells. Unlike GMR and MTJ, hybrid Hall effect magnetic memory cells combine a ferromagnetic storage element and an integrated Hall effect device to read information by sensing magnetization polarities. For example, a high-mobility thin film Hall sensor (also called a Hall cross due to four perpendicularly oriented leads connected to the sensor) can be used as an excellent local magnetometer for measuring the strength of field generated by ferromagnetic films or structures due to its high sensitivity and tolerance of broad range of temperatures. This concept utilizes the well-known Hall effect. When a current flows through a semiconductor in the presence of a transverse magnetic field, the mobile charges drift in a direction perpendicular to both the electric and magnetic fields because of the Lorentz force. This gives rise to a transverse voltage difference called Hall voltage. The reversed magnetic field also alters the polarity of the voltage, making the Hall probe a suitable tool for recording binary information.
The Company will face intense competition when its technologies are developed to a point at which they may be sold and/or licensed. The Company will be required to introduce its technologies into a well developed market and compete with major corporations who manufacture, sell and license existing memory products such as DRAM, SRAM, EPROM, EEPROM and Flash memory. The market for memory technologies is dominated by major corporations who have established market segments for their memory technologies and products, and have significantly greater financial and other resources which are required to design, develop, manufacture, market, sell and license their products and technologies. Many of these major corporations have worldwide wafer manufacturing and integrated circuit production facilities.
The success of the Company's Technology will be determined by the following factors for which it has not yet been tested or measured: (i) the ability to build fully functional sub-micron scale devices for specific applications; (ii) the ability of manufacturers to incorporate the technology into existing manufacturing capabilities without significant retooling and material costs; (iii) price competitiveness; and (iv) availability and costs of raw materials.
After completion of the development of the company's Technology, the ability of the Company to compete successfully will depend on elements outside of its control, including the rate at which customers incorporate the Company's Technology into their products, the success of such customers in selling those products, the Company's protection of its intellectual property, the number, nature and success of competitors and their product introductions, and general market and economic conditions. In addition, the Company's success will depend on its ability to develop, introduce, and license or sell in a timely manner its technology or products incorporating its technology and to compete effectively on the basis of factors such as speed, density, die size and packaging.
Recent Developments
In June 2002, the Company's management determined that its research and development operations required restructuring due to financial constraints, in order to continue the development of its magnetic non-volatile memory technology. Accordingly, the Company commenced restructuring its operations in July 2002 to achieve an orderly transition of its R&D program. As part of this restructuring, Pageant USA closed its Lee's Summit, MO facility by August 31, 2002 and Micromem downsized its head office in Toronto by end of the fiscal year, October 31, 2002. Micromem and Pageant USA terminated Dr. Dale Hensley as Chief Operating Officer effective as of September 24, 2002. Pageant USA terminated all of its other employees by October 31, 2002. Dr. Hensley resigned as a director of Micromem on October 9, 2002 and as a director of Pageant USA on September 26, 2002. In September 2002, Pageant USA terminated its agreement with Townsend Capital Inc. pursuant to which Pageant USA occupied the offices, laboratory and clean room it had occupied at Summit Technology Campus, Lee's Summit, Missouri.
Infrastructure Agreements with University of Toronto
On November 1, 2002 ("effective date"), Micromem entered into an Infrastructure Agreement with the University of Toronto, to fund the assembly of a facility for research and development and fabrication of Magnetic Memory ("MMF").
Under the terms of the agreement, Micromem has committed to contribute $231,140 (CDN$360,000) in cash to fund the direct costs of MMF. The sum is payable to University of Toronto as follows:
i. $120,000 on
execution of agreement, which was paid on November 28, 2002;
ii.
$120,000 at end of the two months following the effective date; and
iii.
$120,000 at end of the four months following the effective date.
University of Toronto and MMO
On October 24, 2002, Micromem entered into a 2-year research collaboration agreement ("U of T Research Collaboration Agreement") with Materials and Manufacturing Ontario ("MMO"), the University of Toronto, and Dr. Harry Ruda, Chair Professor in Nanotechnology. Through the collaboration, Micromem will continue its involvement in the research and development of magnetic memory technology, which will be carried out by a highly skilled research team headed and assembled by Dr. Ruda. Under the agreement, Micromem and MMO will each provide (CDN) $272,000 of funding and the combined (CDN) $544,000 will be used to cover the operating expenses of the research collaboration over a term of two years. Under the agreement, Micromem will maintain its ownership of its portfolio of patents and intellectual property to date.
Micromem will have the first right to an exclusive and perpetual worldwide sub-license for all uses of the technology developed under the collaboration (except that the University may use the technology for educational and research purposes). MMO will be entitled to receive a royalty on Micromem's manufacturing revenues from the sale of products incorporating the technology developed under the collaboration. A separate royalty will be negotiated in the future on revenues to be generated by Micromem from sub-licenses of the technology developed under the collaboration.
The research collaboration agreement contemplates a number of milestones under a comprehensive research plan. The research will be carried out from research facilities at the University of Toronto.
MMO is one of four Ontario Centres of Excellence (OCE) established by the provincial government to promote commercial research partnerships between universities and industry. The OCE program is funded by the Ministry of Enterprise, Opportunity and Innovation; and is part of the provincial government's $2 billion investment in Ontario's knowledge economy making Ontario more competitive through innovation in science and technology
FabTech Inc.
On May 1, 2001, Pageant Technologies (USA) Inc., a wholly owned subsidiary of Micromem, entered into a support services agreement ("Fabtech Agreement") with Fabtech Inc. located in Lee's Summit, Missouri. Under the agreement, as amended from time to time, during the 2002 fiscal year, FabTech provided access to its equipment and facilities and assigned engineering and other technical staff to work directly with Micromem's research and development team at FabTech's facilities. The objective of the relationship was to facilitate the fabrication of samples using Micromem's HEMRAM™ memory design. Pageant USA terminated the Fabtech Agreement effective as of August 31, 2002.
Honeywell FM&T
On December 9, 1999, Pageant USA, a subsidiary of Micromem, entered into an Agreement (the "DOE Agreement") with AlliedSignal Federal Manufacturing & Technologies ("AlliedSignal") operating under contract with the US Department of Energy ("DOE") to conduct an engineering evaluation of the Company's technology. AlliedSignal was subsequently acquired by Honeywell, Inc., which assumed responsibility for both performance of the DOE Agreement and management of the DOE Facility through Honeywell Federal Manufacturing & Technologies ("Honeywell FM&T"). The DOE Agreement was subsequently amended on July 10, 2000 to expand the scope of work to be completed by Honeywell FM&T. Pursuant to the amended DOE Agreement, Honeywell FM&T agreed that, in addition to providing an evaluation of the technology, it would provide engineering and manufacturing services to Pageant. The DOE Agreement terminated in August 2002.
Agreement to Purchase Estancia Interests
On December 10, 2000, Micromem and Pageant International entered into an agreement (the "Purchase Agreement") with Estancia Limited and Richard M. Lienau ("Lienau") to purchase from Estancia and Lienau all interests (the "Estancia Interests") in the VEMRAM™ Patents and the VEMRAM™ technology and all other rights, interests and entitlements held by Estancia and Lienau as set forth in the Joint Ownership and Licensing Agreement. The Purchase Agreement is subject to all required approvals from securities regulatory authorities.
Under the Purchase Agreement which closed on March 9, 2001, Pageant International agreed to pay a purchase price of $50.0 million (the "Purchase Price") to Estancia, as follows:
i. |
|
$10.0 million was paid on closing
(after receipt of regulatory approvals), in the form of 2,007,831 common
shares of Micromem (or $8.0 million worth of Micromem's common shares ("Micromem
Shares") based on the close price on the closing date, being $3.98 per
share) and $2.0 million in cash;
|
ii. |
$20.0 million, will be paid
if and when either: (a) certification is received from Honeywell Federal
Manufacturing & Technologies that fully integrated, randomly addressable
memory matrices of VEMRAM™ technology have met certain stipulated
performance standards, or (b) Micromem or any of its affiliates executes a
definitive agreement for the sale or licensing of the VEMRAM™ technology to
an arm's length third party for any commercial purposes other than testing
or evaluation of the technology; payable in the form of cash and Micromem
Shares to be determined by Pageant International provided that a minimum of
50% of the $20.0 million shall be paid in Micromem Shares valued at the
close of trading on the date of such certification receipt, sale or
licensing; and
|
|
iii. | $20.0 million, will be paid if and when Micromem or any of its affiliates executes a definitive agreement for the sale or licensing of any technology (including the VEMRAM™ Technology) owned by Micromem to an arm's length third party for any commercial purposes other than testing or evaluation of the technology; payable in the form of cash and Micromem Shares to be determined by Pageant International provided that a minimum of 50% of the $20.0 million shall be paid in Micromem Shares valued at the close of trading on the date of execution of the license. |
Notwithstanding the provisions triggering the two $20.0 million payments (the "Trigger Events"), Pageant International has the right to pay any portion or all of the Purchase Price at any time following the Closing Date through a combination of cash and a number of common shares of Micromem, provided that a minimum of 50% of such payment shall be through the issuance of common shares of Micromem. In the event that one or both of the Trigger Events do not occur prior to three years following the Closing Date, Pageant International shall be deemed to have caused a proportionate interest in the Estancia Interests to be conveyed to Estancia where the proportionate interest is calculated as the ratio of the portion of the Purchase Price remaining unpaid at such date over $50.0 million. In the event that Pageant International or Micromem default in the payment of any portion or all of the Purchase Price when due, Pageant International shall be deemed to have caused a proportionate interest in the Estancia Interests to be conveyed to Estancia where the proportionate interest is calculated as the ratio of the portion of the Purchase Price remaining due and unpaid at such date over $50.0 million.
At the closing of the Purchase Agreement, on March 9, 2001, Estancia was required to and it did enter into a three year technology development agreement with Pageant International for the provision of the services of Richard Lienau in respect of the continued development of VEMRAM™ technology (the "Technology Development Agreement"). The Technology Development Agreement provides for fees to Estancia of $215,000 per annum and a budget for the continued development of VEMRAM™ of up to $500,000 per annum. Effective April 23, 2002, the Technology Development Agreement was amended to extend the term of the agreement for an additional eight months commencing March 9, 2004 through to November 9, 2004, and to provide a reduction of the monthly fees payable to Estancia to $107,500 during the periods from June 1 to December 2002, and during the extended period.
The acquisition of the Estancia Interests under the Purchase Agreement could result in additional payments of cash by Pageant International and additional issuances of Common Shares by Micromem. The amount of cash, if any, to be paid to Estancia and the number of Common Shares, if any, to be issued will depend upon several factors including whether or not the Trigger Events occur prior to three years following the Closing Date and the market price of Micromem's Common Shares on the date of each Trigger Event. The table below sets forth the amount of cash and the number of Common Shares of Micromem that will be required to be paid and issued if both Trigger Events occur, prior to three years following the Closing Date, based on assumed market prices of Micromem's Common Shares of $4.00, $6.00 and $8.00 on both dates on which the Trigger Events occur. The data presented in the table is also based upon the assumption that 25% of the portion of the purchase price due upon each Trigger Event will be paid in cash and the balance of 75% will be paid through the issuance of Common Shares. The actual amounts of cash to be paid and the number of Common Shares to be issued may vary significantly from the amounts and numbers set forth in the table below if one or more of the Trigger Events does not occur prior to three years following the Closing Date, if the market prices of Micromem's Common Shares on the dates of the Trigger Events are different than those assumed in the table below or if the percentage of the Purchase Price payable upon a Trigger Event which is paid in the form of cash or shares varies from 25% and 75% respectively.
Assumed
|
Date of Certification
|
Date of Licensing/Sale
|
Total | |||
#Shares |
Cash $ |
# Shares |
Cash $ |
# Shares (% increase) 3 |
$ |
|
$ 4.00 |
3,750,000 |
5,000,000 |
3,750,000 |
5,000,000 |
7,500,000 (16.1) |
10,000,000 |
$ 6.00 |
2,500,000 |
5,000,000 |
2,500,000 |
5,000,000 |
5,000,000 (10.7) |
10,000,000 |
$ 8.00 |
1,875,000 |
5,000,000 |
1,875,000 |
5,000,000 |
3,750,000 (8.0) |
10,000,000 |
____________________
3 Percentage of Common Shares outstanding on a fully diluted basis, based on 46,700,937 Common Shares outstanding on a fully diluted basis as of October 31, 2002.
Patents and Trademarks
The Company believes that protection of its intellectual property is important to its ability to generate revenues from its technologies in the future. The Company has both issued patents and pending patent applications and also enters into confidentiality and other agreements with third parties and its employees for protection of its intellectual property and trade secrets. The Company intends to continue to actively pursue the protection of its intellectual property. Management will determine from time to time the jurisdictions where protection will be sought which determination will be based on a number of factors including: state of development of the Company's Technology; importance of a particular market for the Company's Technology; costs of pursuing patent protection in a jurisdiction; and financial position of the Company.
The Company's magnetic memory patent portfolio comprises two series of patents and patent applications: (i) those covering VEMRAM™ technology and related technologies and processes; and (ii) those covering HEMRAM™ technology and related technologies and processes.
The Company has applied for registration in respect of the trademark for HEMRAM™ , VEMRAM™ and MICROMEM™ .
Inter-corporate Agreements
During the 2002 fiscal year, Pageant International, a wholly-owned subsidiary of Micromem, was engaged in the development of the VEMRAM™ technology. Pursuant to an agreement between Pageant International and Pageant USA, with effect from January 11, 1999, Pageant International engaged Pageant USA to develop the VEMRAM™ technology using some of the facilities, equipment and personnel of Pageant USA as well as indirectly through outside laboratories and to enter into contracts with third parties for the development of VEMRAM™ technology. Under the said agreement, Pageant International was required to reimburse Pageant USA in respect of all costs directly and indirectly incurred on the project plus a six per cent mark-up.
Memtech International, another wholly owned subsidiary of Micromem, has been established to develop non-volatile memory technology other than the VEMRAM™ technology, known as HEMRAM™ . Pursuant to an agreement between Micromem and Pageant USA, with effect from July 1, 2000, which agreement was assigned as of August 30, 2000 by Micromem to Memtech International, Memtech International engaged Pageant USA to develop Memtech International's technology using some of the facilities, equipment and personnel of Pageant USA and to enter into contracts with third parties for the development of Memtech International's technology. Under that agreement, Memtech International was required to reimburse Pageant USA in respect of all costs directly incurred on the project plus a six per cent mark-up.
With the closure of Pageant USA's research and development operations as described above, no further inter-corporate payments or reimbursements will be required under the aforesaid inter-corporate agreements.
Environmental Matters
The Company is subject to various environmental protection regulations imposed by the government in the jurisdiction where it conducts its development work. The Company is not aware of any current or pending environmental protection laws or regulations that would have a material impact on the Company's capital expenditure requirements or competitive position.
C. Organizational Structure
Micromem has one wholly-owned subsidiary whose total assets constitute more than 10% of the consolidated assets of Micromem for the most recent fiscal year: Pageant Technologies Incorporated ("Pageant International"), which was incorporated under the laws of the Turks & Caicos Islands and continued to Barbados on May 25, 2001, in turn has a wholly-owned subsidiary, Pageant Technologies (USA) Inc. ("Pageant USA"), a corporation incorporated in the State of Utah, USA. Micromem has a second wholly-owned subsidiary, Memtech International Inc. ("Memtech International"), incorporated under the laws of the Bahamas, which in turn has a wholly-owned subsidiary, Memtech International (USA) Inc. ("Memtech USA"), a corporation incorporated in the State of Delaware, U.S.A. Micromem has a third wholly-owned subsidiary, Micromem Technologies B.V., ("Micromem BV" ) , incorporated under the laws of the Netherlands on January 16, 2001, which in turn had a subsidiary, Micromem Technologies S.p.A., ("Micromem Italy" ), a corporation incorporated under the laws of Republic of Italy on January 25, 2001. After the 2002 year end, Micromem Italy was dissolved pursuant to the laws of Italy on December 27, 2002.
Pageant International and Pageant USA will be sometimes jointly referred to in this Form 20F as "Pageant". Memtech International and Memtech USA will be sometimes jointly referred to in this Form 20F as "Memtech". Micromem BV and Micromem Italy will be sometimes jointly referred to in this Form 20F as "Micromem Europe". Micromem, Pageant International, Pageant USA, Memtech International, Memtech USA, Micromem BV and Micromem Italy will be sometimes collectively referred to in this Form 20F as the "Company." The following chart sets forth the corporate organizational structure at the date of this Form 20F.
D. Facilities
Micromem maintains its corporate headquarters in Toronto, Ontario, Canada. The space occupied by Micromem consists of 3,987 square feet of commercial office space and is occupied by Micromem pursuant to a lease that expires December 29, 2005.
ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS
This discussion and analysis of financial condition and results of operations for the years ended October 31, 2002, 2001 2000, 1999 and 1998 should be read in conjunction with the consolidated financial statements and related notes in this report, which are prepared in accordance with Canadian generally accepted accounting principles (Canadian GAAP). These principles differ in certain material respects from United States generally accepted accounting principles (U.S. GAAP). The differences as they affect the consolidated financial statements of the Company are described in Note 17 to the Company's 2002 consolidated financial statements.
A. Operating Results
The following table sets forth certain selected financial information of the Company:
Selected statement of operations and deficit information
(all amounts in United States dollars)
Years ended October 31, |
|||||||||||||||
|
|
2002 |
|
|
2001 |
|
|
2000 |
|
|
1999 |
|
|
1998 |
|
Interest & other income |
$ (165,892) |
$ (196,520) |
$ (140,231) |
$ (1,303) |
$ (2,571) |
||||||||||
Loss for the period |
12,733,015 |
4,559,625 |
7,259,356 |
5,207,787 |
499,742 |
||||||||||
Loss per share-basic & diluted |
0.27 |
|
0.1 |
|
0.19 |
|
0.14 |
|
0.02 |
Selected balance sheet information
(all amounts in United States dollars)
Years ended October 31, |
|||||||||||
2002 |
2001 |
2000 |
1999 |
1998 |
|||||||
Working capital (deficiency) |
$ 985,551 |
$ 3,455,108 |
$ 1,076,127 |
$ (3,173,096) |
$ (516,425) |
||||||
Capital Assets |
98,654 |
336,839 |
381,125 |
55,097 |
15,334 |
||||||
Total Assets |
1,583,422 |
14,454,470 |
2,219,987 |
585,327 |
164,020 |
||||||
Shareholder's equity (deficiency) |
1,391,903 |
14,124,918 |
1,684,775 |
(3,095,695) |
(500,991) |
Fiscal 2002 Compared to Fiscal 2001
The Company had no operating revenue, its only activities being the development of its memory technologies. Its only income during 2002 was $165,892 (2001: $196,520) being principally the interest it earned on excess funds deployed in short-term deposits and revenue generated through an engineering services contract.
Costs and expenses have increased from $4,725,931 in 2001 to $12,934,444 in 2002. The increase includes a $10,000,000 write down of royalty rights, which, when excluded from costs and expenses would result in a decrease of 37.9% of costs and expenses when compared to similar costs and expenses in 2001.
In March 2001, Micromem's wholly-owned subsidiary, Pageant International, purchased a 40% gross profits royalty ("Estancia Royalty") related to patents and patent applications for VEMRAM™ technology ("VEMRAM Patents") and the remaining 50% interest in the VEMRAM™ Patents and all rights, entitlements and interests held by Estancia Limited and Richard Lienau under the Joint Ownership and Licensing Agreement dated as of September 17, 1997 pursuant to an asset purchase agreement (the "Asset Purchase Agreement") among Micromem, Pageant International and Estancia Limited and Richard Lienau for a purchase price of $10 million (which was paid at closing) and a further maximum of $40 million to be paid upon certain stipulated milestones being met. During the year, the Company decided to restructure its operations by closing its research and development facility and adopted a plan to continue its research and development program through a research collaboration with the University of Toronto. Micromem determined that there was significant uncertainty that any amounts would have become payable in respect of the Estancia Royalty. Accordingly, it was determined that a write down of the Estancia Royalty rights in the amount of $10,000,000 was appropriate under current generally accepted accounting principles. Notwithstanding the write down, Micromem is committed to continue its research and development of magnetic memory technology through its research collaboration with the University of Toronto.
During the year, the Company expended $1,601,624 (2001: $2,212,679) related to its efforts on research and development of its memory technologies, representing 54.6% (2001: 46.8%) of total expenditures (excluding the royalty rights write down). During the fourth quarter of 2002, Micromem entered into a two year research collaboration agreement whereby researchers at the University of Toronto will undertake the research and development of magnetic memory technology in collaboration with Micromem. Furthermore, Micromem was successful in obtaining matching funds from Materials and Manufacturing Ontario (MMO – a non profit organization) pursuant to a research collaboration agreement among Micromem, the University of Toronto, Dr. Harry Ruda and MMO. Over the two-year period, Micromem will provide CDN$272,000 (approximately $175,000) with matching contributions from the MMO towards the research and development to be undertaken under the research collaboration. In the fourth quarter of 2002, Micromem paid $87,432 (CDN$136,000) against its commitment. Micromem will have the first right to an exclusive and perpetual worldwide sub-license for all uses of the technology developed under the collaboration. MMO will be entitled to receive a royalty on Micromem's manufacturing revenues from the sale of products incorporating the technology developed under the collaboration.
The Company has also continued its efforts to reduce administrative expenses in all areas of operation. The Company's facilities in Lee's Summit have been closed and all employees at the facility were terminated. The Company has also undertaken to control costs performed by outside service providers by performing the work in-house. Furthermore, Micromem has downsized its head office which will continue to reduce costs into the future. As a result of these efforts, general administration expenses decreased by 13.9% from $403,178 in 2001 to $347,256 in 2002; professional fees decreased by 44.5% from $473,653 in 2001 to $262,927 in 2002; travel and entertainment decreased by 64.3% from $205,757 in 2001 to $73,385 in 2002.
Wages and salaries decreased 59.0% from $1,372,375 in 2001 to $562,532 in 2002 as a result of decreasing employee levels (as discussed above) and as a result of changes to the Chairman and CEO's 2001 employment agreement, with effect from November 1, 2001. Effective February 13, 2002, Mr. Fuda resigned as President and Chief Executive Officer of Micromem but continued as Chairman and a director of Micromem and as a director of certain subsidiaries of Micromem. Mr. Fuda's compensation was reduced, with effect from November 1, 2001, to $1.00 per year.
Amortization of patents and trademarks commenced in 2002 amounting to an expense of $31,338. Patents and trademarks will be amortized over 10 years.
Amortization of capital assets decreased from $65,298 in 2001 to $40,635 in 2002 as a result of dispositions of assets due to downsizing.
Micromem had a net loss of $12,733,015 for 2002 or $0.27 loss per share compared to a net loss of $4,559,625 in 2001 or $0.10 per share. The effect on loss per share of the royalty write down in 2002 was $0.22 per share.
Fiscal 2001 Compared to Fiscal 2000
The Company had no operating revenue, its only activities being the development of its memory technologies. Its only income during 2001 was $196,520 being principally the interest it earned on excess funds held in short-term deposits.
Costs and expenses decreased 35.9% to $4,725,931 during 2001 from $7,374,587 during 2000.
The Company continued to focus its efforts in progressing the research and development of its memory technologies by incurring $2,212,679 during 2001 (2000: $1,205,777) that is 84% higher than what was expended during 2000. Since inception, the Company had expended a total of $3,923,744 as direct costs relating to the research and development of its memory technologies by the end of 2001. The Company had entered into a services agreement with Fabtech Inc., a semi-conductor company, to support the further development of the Company's technologies. In the last 4 months of 2001, the Company employed 5 additional research engineers with varied skills and experience, to expand the development efforts.
The share compensation costs of $754,125 (2000: $3,247,721), included in Wages and Salaries, relate to options exercised by the Chairman that were granted under his 2000 Employment and Option Agreement ("2000 Employment Agreement") and the value of shares that are accrued under his new employment agreement ("2001 Agreement") that commenced on January 1, 2001 and that was approved at the annual meeting of shareholders of the Company on March 14, 2001. The Chairman exercised 714,686 options that were granted to him under the 2000 Employment Agreement on January 17, 2001. The compensation cost under the 2000 Employment Agreement for 2001 includes a credit of $677,420. An accrual of $1,431,545 has been made for the value of shares that are accrued but not issued under the 2001 Agreement at October 31, 2001. The 2000 share compensation costs of $3,247,721 relate to compensation agreements the Company had with the Chairman and Mast Holding (Bermuda) Ltd., a company controlled by the former President and Chief Executive Officer of the Company.
Professional fees decreased 57% to $473,653 in 2001 from $1,086,839 in 2000 reflecting primarily legal and accounting fees incurred in 2000 related to the preparation and filing of the Company's registration statement under US securities laws. The reduction in professional fees is also attributable to the addition of a General Counsel and a Chief Financial Officer to the management team.
Wages and salaries (excluding the share compensation costs) increased 41% to $618,250 in 2001 from $440,578 in 2000 principally due to the hiring of additional employees to meet the requirements of an expanding operation.
Amortization expenses increased in line with the increase in capital assets acquired to help the progress of the research and development efforts, excluding the one-time impairment loss of $140,000 recorded in 2000.
Micromem had a net loss of $4,559,625 for 2001 or $0.10 per share, a decrease of 38% over the net loss of $7,259,356 for 2000 or $0.19 per share.
Unaudited quarterly financial information
(all amounts in United States dollars)
Quarter ended, |
October 31, |
July 31, |
April 31, |
January 31, |
October 31, |
July 31, |
April 31, |
January 31, |
2002 |
|
2001 |
||||||
Total Revenue |
57,743 |
27,931 |
66,547 |
13,671 |
49,147 |
39,643 |
57,020 |
50,710 |
Loss for the period |
10,423,341 |
628,603 |
797,439 |
883,632 |
501,722 |
1,343,816 |
1,351,559 |
1,362,528 |
Loss per share: |
0.22 |
0.01 |
0.02 |
0.02 |
0.01 |
0.03 |
0.03 |
0.03 |
Basic and diluted |
Notes:
1. The decrease in the loss for the quarter ended October 31, 2001 is principally due to the reversal of $677,420 in this quarter, relating to the 2000 compensation agreement with the Chairman, due to the decline in stock price between October 31, 2000 and the vesting date of January 2, 2001.
2. The increase in the loss for the quarter ended October 31, 2002 is due to a $10,000,000 write down of royalty rights, the effect of which is $0.22 per share.
B. Liquidity and Capital Resources
Liquidity
The Company currently has no cash flow from operations and will have none until it is in a position to either license or directly produce and sell products utilizing its memory technologies.
Micromem currently has no lines of credit in place and must obtain equity financing from investors and from persons who hold outstanding options in order to meet its cash flow needs until it can generate revenues.
Micromem has granted to its directors, officers and other employees a number of options to purchase shares at prices that are at or above market price on the date of grant. None of the optionees has any obligation to exercise his options and there can be no assurance that Micromem will realize any funds.
Capital Resources
Micromem had no material commitments for capital expenditures as of October 31, 2002 or 2001. In March 2001, Micromem and its wholly owned subsidiary, Pageant International, completed the Asset Purchase Agreement described above. The total consideration payable in respect of the purchased assets under the Asset Purchase Agreement is $50 million in the form of cash and shares. Of this amount, $10 million was paid at closing through a cash payment of $2.0 million and the issuance by Micromem of 2,007,831 common shares valued at $3.98 per share. The balance of $40 million is payable in two equal amounts of $20 million each upon achievement of certain stipulated milestones provided that a minimum of 50% of each $20 million payment shall be in the form of shares of Micromem. None of the stipulated milestones have been met and therefore no amounts have been paid toward the balance of the $40 million purchase price. If no further payments toward the purchase price are made to Estancia under the Asset Purchase Agreement, Pageant is deemed to have conveyed back a percentage of the VEMRAM™ Patents and to have granted a gross profits royalty to Estancia Limited such that Pageant would remain holding a 60% interest in the VEMRAM™ Patents and it would be required to pay a 32% gross profits royalty to Estancia Limited in respect of the VEMRAM™ technology.
Subsequent to the year end, Micromem entered into an infrastructure agreement with the University of Toronto to fund the assembly of a facility for research and development and fabrication of magnetic memory, which, among other things, will be used for research and development related to collaborations between the University and Micromem. Micromem has committed to contribute $231,140 ($360,000 in Canadian funds) in 2003 pursuant to the agreement.
Change in accounting policy
Effective November 1, 2001, the Company changed its accounting policy for patents and trademarks to be recorded at cost less accumulated amortization which is provided on a straight-line basis over ten years. In prior years, the Company accounted for its patents and trademarks at cost and amortization was to commence on an appropriate basis to charge off the cost over the future benefit, not exceeding the legal life, when sales commence. There was no material impact on prior years consolidated financial statements and accordingly, the comparative consolidated financial statements have not been restated.
For the year ended October 31, 2002, the change in accounting policy resulted in an increase in amortization expense and net loss by $31,338 and there was no material impact on net loss per share.
Critical accounting policies
The preparation of the Company's consolidated financial statements is based on the selection and application of critical accounting policies, some of which require management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates. The Company believes that the following are some of the critical judgment areas in the application of its accounting policies that currently affect the Company's financial condition and results of operations.
The Company had royalty rights capitalized as an intangible asset on its balance sheet. The determination of the recoverability of this amount and whether or not this asset is impaired involves significant judgments. In assessing the recoverability of this intangible assets, the Company considered whether the recoverability of the asset was probable or imminent to assess the future benefit, also considered the degree of certainty to justify carrying the intangible asset forward. Notwithstanding the fact that management has not abandoned the continued development of the technology and is working to pursue the development through recent arrangements with the University of Toronto, and management anticipated it will achieve commercialization, for accounting purposes an impairment in the asset exists based on the significant uncertainty that royalties would be payable to Estancia in the foreseeable future. Accordingly, management has written down the balance of the royalty rights.
ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES
A. Directors and Executive Officers
The Directors, Executive Officers and other key personal of Micromem as at March 1, 2003 are set forth belo w:
Name |
Age |
Position |
Salvatore Fuda |
67 |
Chairman of the Board of Directors |
Joseph Fuda |
42 |
President, Chief Executive Officer and Director |
Manoj Pundit |
38 |
Executive Vice-President, General Counsel, Secretary and Director |
Andrew Brandt |
64 |
Director |
Stephen Fleming |
53 |
Director |
Charles Harnick |
52 |
Director |
George Kennedy |
62 |
Director |
David Sharpless |
52 |
Director |
Steven Van Fleet |
48 |
Director |
Antonio Lopes |
40 |
Chief Financial Officer |
Salvatore Fuda is and has served as Chairman of the Board of Micromem since January 11, 1999 and a Director of Micromem since 1992. He served as President and Chief Executive Officer from June 2000 through to February 13, 2002. From 1992 to January 11, 1999 he also served as Secretary of Micromem. He served as President and Chief Executive Officer of Ontex Resources Limited (TSE) from 1986 to December 1998 and as Chairman of the Board of Ontex Resources Limited since that date. He is and has served as Chairman and director of Pifher Resources Inc. (TSX Venture Exchange) since June, 2002. He is the father of Joseph Fuda.
Joseph Fuda is and has been President, Chief Executive Officer and Director since February 13, 2002. Prior thereto he served as Manager, Strategic Alliances for Micromem since February 2001. Prior thereto, he served as a consultant to Micromem since November 2000. Prior thereto he served as a Vice-President and a Director of IPO Capital Corp since April 1999. Mr. J. Fuda has served as a director of Micromem since February 13, 2002. He is the son of Salvatore Fuda.
Manoj Pundit is and has served as Micromem's Executive Vice President and General Counsel since July 2000 and joined the Board of Directors in March 2001. He has also been a partner, since December 1995, at Chitiz Pathak LLP, a Toronto law firm serving clients in the securities and investment industries, including issuers and dealers on a full range of securities transactions. Mr. Pundit holds a LL.M. in Taxation from Osgoode Hall Law school and a LL.B. and B.Sc. (Math) from the University of Alberta. Mr. Pundit has served as a director of Micromem since March 2001.
Andrew Brandt is and has been Chairman and Chief Executive Officer of the Liquor Control Board of Ontario ("LCBO") since February 1991. The LCBO is the largest single purchaser of alcohol beverage products in the world with annual sales exceeding two billion dollars Canadian. Prior to his appointment to the LCBO, Mr. Brandt served as Leader of the Ontario Progressive Conservative Party from 1987 to 1990. He has previously served as the Minister of Industry and Trade, Minister of Environment and Mayor of Sarnia, Ontario. Mr. Brandt has served as a director of Micromem since June 2000
Stephen B. Fleming is and has served as Managing Director of Kismet Limited since June 2001; prior thereto he served as Managing Director of Barefoot Enterprises since April 1999; prior thereto, he served as President of Pageant Technologies (USA) Inc. from July 1997 to April 1999; prior thereto, Mr. Fleming was Executive Vice-President of International Ion from August 1994 to April 1997. Previously, Mr. Fleming was responsible for planning MCI's wireless data products, intelligent network and frame relay international initiatives, and served as director of engineering for international business development for Telecom U.S.A. Mr. Fleming has worked with numerous emerging technology companies in consulting and management capacities. Mr. Fleming has served as a director of Micromem since January 1999.
Charles Harnick is and has served as Senior Advisor for the Jeffery Group Ltd., a public affairs management firm since June 2000; he is also President and Chief Executive Officer of Ontex Resources Limited (TSE) and has served in such capacities since March, 2000. Mr. Harnick has been a practicing lawyer with Sutts, Strosberg LLP since December 2001. He was the Attorney-General of Ontario from June 1995 to June 1999. Mr. Harnick has served as a director of Micromem since June 2000.
George A. Kennedy is and has served as managing partner of Source International (an international consulting firm in the Metropolitan Washington D.C. area) since March 1997. In 2001, he was Director for Planning and International Development for iGate Inc., a broadband technology company in Louisville, KY. From 1993 until1996, Mr. Kennedy served as U.S. Consul General in Toronto, Canada, and prior thereto he held senior positions with the US Departments of State and Commerce in Washington D.C. Currently, he is an Executive Editor of the Black Business Journal of Houston, TX. Mr. Kennedy has served as a director of Micromem since June 2000.
David Sharpless is Chairman, Maverick Inc., a family investment corporation. From 2000 to September 2001, he was President, International of CIT's Vendor Technology Finance unit. In this capacity, he was responsible for CIT's international vendor finance business, covering CIT's operations in Canada, Europe, Latin America, Asia Pacific, Australasia. Prior thereto, Mr. Sharpless was Newcourt Credit Group Inc.'s Deputy Chairman and was responsible for international operations for Newcourt Financial. David is a graduate of Osgoode Hall Law School and is a member of the bar of Ontario. Mr. Sharpless has served as a director of Micromem since March 2001.
Steven Van Fleet is and has been Program Director for the Silent Commerce/Smart Packaging Initiative at International Paper Company since November 1999. From January 1999 to November 1999, he was Program Director for Process and Product Uniformity and from March 1996 to December 1998 he was the Director for Control Systems Development at International Paper in Cincinnati, Ohio. He is also presently on the Board of Overseers for the Massachusetts Institute of Technology Auto ID Center.
Antonio Lopes is currently the Chief Financial Officer of several companies. Since November 1, 2002, he has been CFO of Micromem; since 1993, he has been CFO of Federal White Cement; since 1997, he has been CFO of Ontex Resources Limited; and since 1997, he has been CFO of Pifher Resources Inc. From 1994 to 1998, he was CFO of Fortune Mineral Limited. From 1989 to 1993, he was a staff accountant at Ernst &Young LLP. Mr. Lopes is a Chartered Accountant and holds an MBA from the University of Toronto.
There are no arrangements or understandings between any director and any other person pursuant to which the director was selected as a director or executive officer. Each director holds office until the next annual meeting of shareholders or until his or her successor is elected or appointed, unless his or her office is earlier vacated according to the provisions of the by-laws of the Micromem or the Business Corporations Act (Ontario).
Other than a father/son relationship between Salvatore Fuda (father) and Joseph Fuda (son), there is no family relationship between any director or executive officer and any other director or executive officer.
B. Compensation
Annual Compensation |
Long-Term Compensation |
|||||||
Awards |
Payouts |
|||||||
Name and
|
Year |
Salary
|
Bonus
|
Other Annual Compensation (US$) |
Securities
|
Restricted Shares or Restricted Share Units ($) |
Long Term Incentive Plan Payouts ($) |
All other
|
Joseph Fuda
Chief Executive Officer 1 |
2002 |
100,000 |
- |
- |
- |
- |
- |
- |
Salvatore Fuda, Chairman
Former Chief Executive Officer and President 1 |
2002
|
-
745,125 2 2,463,962 2 |
-
|
-
|
-
|
-
|
-
|
-
|
Manoj Pundit, Executive
Vice President and General Counsel 5 |
2002
|
162,066
|
-
|
-
|
-
|
-
|
-
|
-
|
Dale Hensley, Chief Operating Officer 8 |
2002
|
216,577
308,685 - - |
-
|
-
|
-
|
-
|
-
|
-
|
Raj Viswanathan, Chief Financial Officer 10 |
2002
|
111,583
|
-
|
-
|
-
|
-
|
-
|
-
|
Robert Patterson, Former
President 13 |
2002
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Notes:
(1) | Salvatore Fuda has served as Chairman since January 11, 1999. He served as President and Chief Executive Officer from June 2000 through to February 13, 2002. Joseph Fuda was appointed Chief Executive Officer on February 13, 2002. All of Joseph Fuda's options were cancelled after the 2002 fiscal year end. |
(2) | Salvatore Fuda (or companies controlled by him) was a party to consulting and employment agreements with the Corporation pursuant to which Mr. Fuda received, as compensation, a number of common shares based on formulas prescribed by those agreements. The dollar value represents the value of the shares accrued due to Mr. Fuda at the end of the fiscal years ended October 31, 1999, October 31, 2000, and October 31, 2001. |
(3) | 1.0 million at $3.125 vesting January 31, 2002 and 714,683 options at $0.10 vesting January 3, 2001 and expiring January 2, 2002. |
(4) | 125,000 of these options vested on June 30, 2000 and the remaining options vested on June 30, 2001. All of these options were cancelled after the 2002 fiscal year. |
(5) | Mr. Pundit is employed as Executive Vice-President and General Counsel of the Corporation. For the fiscal year ended October 31, 2000, Mr. Pundit was an officer of the Corporation for approximately 3 1/2 months. |
(6) | Vesting on take-over. |
(7) | Pursuant to his employment agreement, Mr. Pundit was granted options for the purchase of up to 500,000 common shares, 200,000 of which vested on July 17, 2000, 200,000 of which vested on January 17, 2001 and the remaining 100,000 of which vested on July 17, 2001. All of these options were cancelled after the 2002 fiscal year. |
(8) | Dr. Hensley was employed as Chief Operating Officer from February 21, 2001 to September 24, 2002. For the fiscal years ended October 31, 2001 and 2002, Dr. Hensley was an officer of the Corporation for approximately eight months and 11 months, respectively. |
(9) |
250,000 of these options vested on March 1, 2001 and the remaining 250,000 options vested on March 1, 2002. |
(10) |
Mr. Viswanathan was employed as Chief Financial Officer between June 5, 2000 and October 31, 2002. For the fiscal year ended October 31, 2000, Mr. Viswanathan was an officer of the Corporation for approximately five months. |
(11) |
150,000 of these options vested on June 30, 2001; 250,000 would vest on take-over or change of control of the Company. |
(12) | The vesting terms of these options were revised so that 20,000 vested on June 29, 2000 and remaining 80,000 vested on August 31, 2001. |
(13) | Mr. Patterson was appointed President on March 10, 1999 and ceased to serve as President on June 29, 2000. For the fiscal years ended October 31, 1999 and October 31, 2000, Mr. Patterson was an officer of the Corporation for approximately 8 months and 4 months, respectively. |
The aggregate direct compensation paid or accrued on behalf of all other directors as a group during 2002 was $8,000. This amount includes directors' fees and expenses for non-employee directors. None of the non-employee directors have agreements with Micromem that provide for benefits upon termination of service.
Micromem has adopted a stock option plan. Options are offered to directors, executive officers and employees to purchase Common Shares at an exercise price equal to or above the market price for the Common shares at the date that the options are granted. No options were granted during 2002. As at the Company's fiscal year ended, October 31, 2002, 5,380,000 options were outstanding, of which 2,995,000 had vested and were exercisable, with exercise prices ranging between $2.20 and $7.06 per share. Subsequent to the year end all outstanding options were cancelled.
C. Board Practices
Committees of the Board
Audit Committee
The board of directors has appointed an Audit Committee consisting of three independent directors. The members of the Audit Committee are Andrew Brandt, Charles Harnick and David Sharpless. The Audit Committee is responsible for the integrity of the Micromem's internal accounting and control systems. The committee receives and reviews the financial statements of Micromem and makes recommendations thereon to the Board prior to its approval by the full Board. The Audit Committee communicates directly with Micromem's external auditors in order to discuss audit and related matters whenever appropriate.
Compensation Committee
Micromem does not have a Compensation Committee. Micromem's executive compensation program is administered by the board of directors and meets on compensation matters as and when required.
D. Employees
The company has seven officers and employees of which four are in a management capacity, none are in a R&D capacity and two are in an administrative capacity. This includes a Chairman, a Chief Executive Officer and President, an Executive Vice-President and General Counsel and a Chief Financial Officer, and three support staff, all of whom work from Micromem's executive offices in Toronto, Canada. All research and development is carried out by Dr. Harry Ruda and a research team employed by the University of Toronto under the U of T Research Collaboration Agreement.
At the beginning of the 2002 fiscal year, the Company had a total of 17 employees in the following categories: (i) five management personnel (including the Chairman, President and C.E.O., a Chief Operating Officer, an Executive Vice-President and General Counsel, a Chief Financial Officer and a Manager-Strategic Alliances); (ii) five administrative personnel (including a shareholder communications person and support staff); and (iii) seven research engineers.
Micromem considers its relations with its employees to be good.
E. Share Ownership
Name |
Shares Owned |
Options Held |
Options Exercise Price |
Expiration Date |
Joseph Fuda |
- |
- |
- |
N/A |
Salvatore Fuda |
1,429,275 |
- |
N/A |
N/A |
Manoj Pundit |
2,478 |
- |
- |
N/A |
Dale Hensley |
- |
- |
N/A |
N/A |
Raj Viswanathan |
- |
- |
N/A |
N/A |
Robert Patterson |
- |
- |
N/A |
N/A |
ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS
A. Major Shareholders
Not Applicable.
B. Related Party Transactions
During fiscal year ended October 31, 2002, the Company paid $23,846.93 to legal firms in which directors of the Company or subsidiaries are partners.
C. Interests of Experts and Counsel
Not Applicable.
ITEM 8. FINANCIAL INFORMATION
A. Consolidated Statements
Dividend Policy
Micromem has never paid a dividend on its securities. Micromem does not anticipate paying dividends in the foreseeable future.
Significant Changes
Except as otherwise disclosed in this report, there has been no significant change in Micromem's financial position since October 31, 2002.
B. Legal Proceedings
The Company's subsidiary, Pageant Technologies (USA) Inc. ("Pageant USA"), has been named as a defendant in legal actions relating to tenant improvements on a leased property, including an action claiming dues of approximately $880,000 alleging breach of contract under a construction contract entered into by Clear Blue Laboratories, Inc. ("Clear Blue"). The landlord of the property is also claiming damages from Pageant USA. Pageant USA assigned its rights under the lease to Clear Blue, however, Pageant USA is allegedly obligated to pay the lease payments should the assignee default under the contract. The landlord is claiming damages of approximately $887,000.
ITEM 9. THE OFFER AND LISTING
Micromem's common shares are traded in the United States and are quoted on the NASD's OTC Bulletin Board. The common shares are quoted under the symbol MMTIF.
The following table sets forth information regarding the high and low prices of the common shares for the periods specified in U.S. dollars.
Period |
High |
Low |
|||||||
|
|
|
|||||||
Last six months: |
|
|
|
|
|
|
|||
February 2003 |
0.13 |
0.09 |
|||||||
January 2003 |
0.14 |
0.09 |
|||||||
December 2002 |
0.15 |
0.09 |
|||||||
November 2002 |
0.36 |
0.13 |
|||||||
October 2002 |
0.14 |
0.05 |
|||||||
September 2002 |
0.17 |
0.05 |
|||||||
Last eight quarters: |
|
|
|
|
|
|
|||
Q4 2002 |
0.17 |
0.05 |
|||||||
Q3 2002 |
0.60 |
0.11 |
|||||||
Q2 2002 |
1.21 |
0.43 |
|||||||
Q1 2002 |
2.50 |
0.83 |
|||||||
Q4 2001 |
3.20 |
1.46 |
|||||||
Q3 2001 |
3.58 |
1.55 |
|||||||
Q2 2001 |
4.50 |
2.03 |
|||||||
Q1 2001 |
5.28 |
1.69 |
|||||||
Last four years: |
|
|
|
|
|
|
|||
2002 |
2.50 |
0.05 |
|||||||
2001 |
5.28 |
1.46 |
|||||||
2000 |
25.12 |
2.50 |
|||||||
1999 |
8.44 |
1.56 |
On February 28, 2003, the last reported sale price for the common shares on the NASD OTC Bulletin Board was $0.093.
ITEM 10. ADDITIONAL INFORMATION
A. Share Capital
Not Applicable
B. Memorandum and Articles of Association
Articles of Incorporation
Incorporation Details and Objects of Micromem
Micromem was incorporated under the laws of the Province of Ontario, Canada, on October 21, 1985 as Mine Lake Minerals Inc. It subsequently changed its name to Avanti Capital Corp. by filing Articles of Amendment on June 23, 1988 and to AvantiCorp International Inc. on April 30, 1992 before becoming Micromem Technologies Inc. on January 14, 1999. The Articles of Incorporation of Micromem provide that there are no restrictions on the nature of the business to be carried on by Micromem.
Summary of Directors Powers and Authorities
The rights, duties, powers and authorities of the Board of Directors of Micromem are set out in the Articles of Incorporation (the "Articles") and by-laws (the "By-Laws") of Micromem and the statutory provisions of the Business Corporations Act (Ontario) ("OBCA"). The following is a selected summary of the Articles, By-Laws and applicable provisions of the OBCA as they relate to selected rights, duties, powers and authorities of the Board of Directors of Micromem.
The Articles of Micromem provide for a minimum of three and a maximum of 12 directors. The OBCA prescribes that an offering corporation must have a minimum of three directors, a majority of whom are Canadian residents and at least one third of whom are not officers or employees of Micromem or its affiliates. The Board of Directors may, between annual shareholders meetings, appoint one or more additional directors to serve until the next annual shareholders meeting provided that the number of directors so added may not exceed by one-third (1/3) the number of directors required to have been electd at the last annual meeting of shareholders.
The Chairman of the Board of Directors or any one director may call a meeting upon the provision of forty-eight hours notice to each director in the manner prescribed in the By-Laws. Any such notice shall include the items of business to be considered at the meeting. A majority of the directors constitute a quorum provided that half of those directors present are Canadian residents. Business cannot be transacted without a quorum. A quorum of directors may vote on any matter of business properly brought before the meeting provided that where a director is a party to a material contract or proposed material contract or has a material interest in the matter to be considered, such director must disclose his or her interest at the earliest possible date, request the conflict be noted in the minutes of the meeting, and with a few limited exceptions enumerated in the By-Laws, refrain from voting on the matter in which the director has a material interest. There is no limitation on the Board of Directors to vote on matters of their remuneration provided such remuneration is disclosed in the financial statements and annual shareholder proxy materials.
The Board of Directors has broad borrowing powers and may, without authorization from the shareholders, (a) borrow money on the credit of Micromem; (b) issue, re-issue, sell or pledge debt obligations of Micromem; (c) subject to restrictions respecting financial assistance prescribed in the OBCA, give a guarantee on behalf of Micromem to secure the performance of an obligation of any person; and (d) mortgage, hypothecate, pledge or otherwise create a security interest in all or any property of Micromem, owned or subsequently acquired, to secure any obligation of Micromem .
A person is qualified to be or stand for election as a director provided such person is at least 18 years of age, is not a bankrupt and is not found to be of unsound mind by a court in Canada or elsewhere. There is no requirement for a director to hold shares of Micromem.
Securities of Micromem
The authorized capital of Micromem consists of an unlimited number of common shares "Common Shares"), of which 46,700,937 shares were issued and outstanding as of October 31, 2002, and 2,000,000 special, redeemable, voting preference shares ("Special Shares"), none of which were outstanding, as of October 31, 2002.
Holders of Common Shares will be entitled to receive notice of, attend and vote at all meetings of the shareholders of Micromem. Each Common Share carries one vote at such meetings. In the event of the voluntary or involuntary liquidation, dissolution or winding-up of Micromem, after payment of all outstanding debts, the remaining assets of Micromem available for distribution will be distributed to the holders of Common Shares. Dividends may be declared and paid on the Common Shares in such amounts and at such times as the directors shall determine in their discretion in accordance with the OBCA. There are no pre-emptive rights, conversion rights, redemption provisions or sinking fund provisions attaching to the Common Shares. Common Shares are not liable to further calls or to assessment by Micromem; provided, however, that pursuant to the provisions of the OBCA, Micromem has a lien on any Common Share registered in the name of a shareholder or the shareholder's legal representative for a debt owed by the shareholder to Micromem.
Holders of Special Shares are entitled to receive notice of, attend and vote at all meetings of the shareholders of Micromem. Each Special Share carries one vote at such meetings. In the event of the voluntary or involuntary liquidation, dissolution or winding-up of Micromem, after payment of all outstanding debts, the holders of the Special Shares shall be entitled to receive, before any distribution of any part of the assets of Micromem among the holders of any other shares, the amount paid up on the Special Shares. The Special Shares are redeemable at the option of Micromem for the amount paid up on the shares. Dividends may not be declared or paid on the Special Shares and transfer of the Special Shares is restricted without the approval of the Directors of Micromem and the prior written consent of the Ontario Securities Commission. The number of Special Shares that may be issued and outstanding at any time is limited to 500,000. There are no pre-emptive rights, conversion rights or sinking fund provisions attaching to the Special Shares. Special Shares are not liable to further calls or to assessment by Micromem; provided, however, that pursuant to the provisions of the OBCA, Micromem has a lien on any Special Share registered in the name of a shareholder or the shareholder's legal representative for a debt owed by the shareholder to Micromem.
Rights and Privileges of Shareholders
Only the registered holders of common shares and special preference shares on the record date are entitled to receive notice of and vote at annual and special meetings of shareholders. Where the items of business affect the rights of shareholders other than common shareholders, a special majority of two-thirds of the votes cast by the affected shareholders at the meeting called for such purpose is required to approve the item of business. Beneficial holders of common shares and special preference shares are also entitled to receive proxy materials in respect of meetings of shareholders in accordance with Canadian Securities Administrators National Instrument 54-101, provided that such proxies are limited in scope to instructing the registered shareholder (usually a brokerage house) on how to vote on behalf of the beneficial shareholder. There are no restrictions on the number of shares that may be held by non-residents other than restrictions set out in the Investment Canada Act (Canada). See "Additional Information - D. Exchange Controls".
There are no provisions in the By-laws regarding public disclosure of individual shareholdings. Notwithstanding this, applicable Canadian securities legislation requires certain public disclosure of persons owning or acquiring common shares in excess of 10% of a corporation's issued and outstanding share capital.
C. Material Contracts
1. |
Research Collaboration Agreement, dated October 24, 2002, among Micromem, Materials and Manufacturing Ontario ("MMO"), the University of Toronto and Dr. Harry Ruda, Chair Professor in Nanotechnology, pursuant to which: (i) Micromem has engaged the University of Toronto to conduct research and development of magnetic memory technology; and (ii) Micromem and MMO will each provide (Cdn.) $272,000 of funding and the combined (Cdn.) $544,000 will be used to cover the operating expenses of the research collaboration over a term of two years; |
2. |
Asset Purchase Agreement, dated December 10, 2000, among Micromem, Pageant International, Estancia Limited and Richard M. Lienau (" Lienau "), pursuant to which: (i) Pageant International purchased from Estancia Limited and Lienau all interests in the VEMRAM™ Patents and the VEMRAM™ technology and all other rights, interests and entitlements held by Estancia and Lienau as set forth in the Joint Ownership and Licensing Agreement and a termination of such agreement; and (ii) Micromem is required to pay to Estancia Limited a purchase price of $50 million, of which $10 million was paid in cash and shares at closing and the balance of $40 million being payable in cash and shares upon certain stipulated milestones being achieved; |
3. |
Technology Development Agreement, dated March 9, 2001, as amended on April 23, 2002, among Pageant International, Estancia Limited and Richard Lienau, pursuant to which: (i) Estancia Limited and Richard Lienau are required to provide services to Pageant International in respect of the continued development of VEMRAM™ technology; and (ii) Pageant International is required to pay monthly fees to Estancia Limited at the rate of $215,000 per annum over a term of three years and eight months, except that the fees payable during the period from June 1 to December 2002 and during the period from March 9, 2004 through to November 9, 2004 will be at a rate of $107,000 per annum; |
4. |
Infrastructure Agreement between Micromem and the University of Toronto, dated November 1, 2002, pursuant to which Micromem agreed to provide funding to the University of Toronto in the amount of $360,000 for the assembly of a magnetic memory facility to be used for research collaborations between Micromem and the University of Toronto. |
D. Exchange Controls
As of the date hereof, the Company is aware of no governmental laws, decrees or regulations in Canada that restrict the export or import of capital, including, but not limited to, foreign exchange controls, or that affect the remittance of dividends or other payments to nonresident holders of Common Shares.
The Company is aware of no limitations under the laws of Canada or the Province of Ontario, or in the charter or any other constituent documents of Micromem on the right of nonresidents of Canada or persons who are not Canadian citizens to hold and/or vote the Common Shares of Micromem.
E. Taxation
Certain Canadian Income Tax Consequences
This discussion under this heading summarizes the .principal Canadian federal income tax consequences of acquiring, holding and disposing of common stock of Micromem for a shareholder of Micromem who is not a resident of Canada but is a resident of the United States and who will acquire and hold a share of common stock of Micromem as capital property for the purposes of the Income Tax Canada (Canada) (the "Canadian Tax Act"). This summary does not apply to a shareholder who carries on business in Canada through a permanent establishment situated in Canada or performs independent personal services in Canada through a fixed base in Canada if the shareholders of Micromem is effectively connected with such permanent establishment or fixed base. This summary is based on the provisions of the Canadian Tax Act and the regulations thereunder and on an understanding of the administrative practices of Canada Customs & Revenue Agency, and takes into account all specific proposals to amend the Canadian Tax Act or regulations made by the Minister of Finance of Canada s of the date hereof. It has been assumed that there will be no other relevant amendments of any governing law although no assurance can be given in this respect. This discussion is general only and is not a substitute for independent advice from a shareholder's own Canadian and US tax advisors.
The provisions of the Canadian Tax Act are subject to income tax treaties to which Canada is a party, including the Canada- United States Income Tax Convention (1980), as amended (the "Convention").
Dividends on Common Shares and Other Income
Under the Canadian Tax Act, a non-resident of Canada is generally subject to Canadian withholding tax at the rate of 25 percent on dividends paid or deemed to have been paid to him or her by a corporation resident in Canada. Micromem is responsible for withholding of tax at the source. The Convention limits the rate to 15 percent if the shareholder is a resident of the United States and the dividends are beneficially owned by and paid to such shareholder, and to 5 percent if the shareholder is also a corporation that beneficially owns at least 10 percent of the voting stock of the payor corporation.
The amount of a stock dividend (for tax purposes) would generally be equal to the amount by which the paid up or stated capital of Micromem and increased by reason of the payment of such dividend. Micromem will furnish additional tax information to shareholders in the event of such a dividend. Interest paid or deemed to be paid on Micromem's debt securities held by non-Canadian residents may also be subject to Canadian withholding tax, depending upon the terms and provisions of such securities and any applicable tax treaty.
The Convention generally exempts from Canadian income tax dividends paid to a religious, scientific, literary, educational or charitable organization or to an organization constituted and operated exclusively to administer a pension, retirement or employee benefit fund or plan, if the organization is a resident of the United States and is exempt from income tax under the laws of the United States.
Dispositions of Common Shares
Under the Canadian Tax Act, a non-resident of Canada is subject to Canadian tax on taxable capital gains, and may deduct allowable capital losses, realized on a disposition of "taxable Canadian property". Shares of common stock of Micromem will constitute taxable Canadian property of a shareholder at a particular time if the shareholder used the shares in carrying on business in Canada, or if at any time in the five years immediately preceding the disposition 25 percent or more of the issued shares of any class or series in the capital stock of Micromem belonged to one or more persons in a group comprising the shareholder and persons with whom the shareholder and persons with whom the shareholder did not deal at "arm's length and in certain other circumstances.
The Convention relieves United States residents from liability for Canadian tax on capital gains derived on a disposition of shares unless:
the value of the shares is derived principally from "real property" in Canada, including the right to explore for or exploit natural resources and rights to amounts computed by reference to production, the shareholder was resident in Canada for 120 months during any period of 20 consecutive years preceding, a and at anytime during the 10 years immediately preceding, the disposition and the shares were owned by them when they ceased to be resident in Canada, or the shares formed part of the business property of a "permanent establishment" that the holder has or had in Canada within the 12 months preceding the disposition. |
Certain United States Federal Income Tax Consequences
The following is a general discussion of certain possible United States federal income tax consequences, under current law, generally applicable to a US Holder (as defined below) of the Company's common shares. This discussion does not address all potentially relevant federal income tax matters (including but not limited to alternative minimum tax considerations) and it does not address consequences peculiar to persons subject to special provisions of federal income tax law, such as those described below as excluded from the definition of a US Holder. In addition, this discussion does not cover any state, local or foreign tax consequences. See " Certain Canadian Income Tax Consequences " above.
The following discussion is based upon the sections of the Internal Revenue Code of 1986, as amended (the "Code"), Treasury Regulations, published Internal Revenue Service ("IRS") rulings, published administrative positions of the IRS and court decisions that are currently applicable, any or all of which could be materially and adversely changed, possibly on a retroactive basis, at any time. This discussion does not consider the potential effects, both adverse and beneficial, of any recently proposed legislation which, if enacted, could be applied, possibly on a retroactive basis, at any time. This discussion is for general information only and it is not intended to be, nor should it be construed to be, legal or tax advice to any holder or prospective holder of the Company's common shares and no opinion or representation with respect to tax consequences to any such holder or prospective holders is made.
Accordingly, holders and prospective holders of the Company's common shares should consult their own tax advisors about the federal, state, local, and foreign tax consequences of purchasing, owning and disposing of the Company's common shares.
US Holders
As used herein, a "US Holder" means a holder of the Company's common shares who is a citizen or individual resident (as defined under U.S. tax laws) of the United States, or, generally a corporation limited liability company, or a partnership created or organized in or under the laws of the United States or of any political subdivision thereof, or a trust whose income is taxable in the United States irrespective of source. This summary does not address the tax consequences to, and a US Holder does not include, persons subject to special provisions of federal income tax law, such as tax-exempt organizations, qualified retirement plans, individual retirement accounts and other tax-deferred accounts, financial institutions, insurance companies, real estate investment trusts, regulated investment companies, broker-dealers, non-resident alien individuals, persons or entities that have a "functional currency" other than the US dollar, shareholders who hold common stock as part of a "straddle", hedging or a conversion transaction and shareholders who acquired their stock through the exercise of employee stock options or otherwise as compensation for services. This discussion is limited to US Holders who hold the common shares as capital assets. This discussion does not address the consequences to a person or entity holding an interest in a US Holder or the consequence to a person of the ownership, exercise or disposition of any warrants, options or other rights to acquire common shares.
Distributions on Common Shares
Subject to the discussion below at "Other Considerations", US Holders receiving dividend distributions (including but not limited to constructive dividends) with respect to the Company's common shares generally are required to include in gross income for United States federal income tax purposes the gross amount of such distributions equal to the US dollar value of each dividends on the date of receipt (based on the exchange rate on such date) to the extent that the Company has current or accumulated earnings and profits, without reduction for any Canadian income tax withheld from such distributions. Such Canadian tax withheld may be credited, subject to certain limitations, against the US Holder's United States federal income tax liability or, alternatively, may be deducted in computing the US Holder's United States federal taxable income by those who itemize deductions. (See more detailed discussion at " Foreign Tax Credit " below.) To the extent that distributions exceed current or accumulated earnings and profits of the Company, they will be treated first as a return of capital up to the US Holder's adjusted basis in the common shares and thereafter as gain from the sale or exchange of the common shares. Preferential tax rates for long-term capital gains are applicable to a US Holder which is an individual, estate or trust. There are currently no preferential tax rates for long-term capital gains for a US Holder which is a corporation.
In the case of foreign currency received as a dividend that is not converted by the recipient into US dollars on the date of the receipt, a US Holder will have a tax basis in the foreign currency equal to its US dollar value on the date of receipt. Generally, any gain or loss recognized upon a subsequent sale or other disposition of the foreign currency, including an exchange for US dollars, will be ordinary income or loss.
Dividends paid on the Company's common shares will not generally be eligible for the dividends received deduction provided to corporations receiving dividends from certain United States corporations. A US Holder which is a corporation may, under certain circumstances, be entitled to a 70 per cent deduction of the United States source portion of dividends received from the Company (unless the Company qualifies as a "foreign personal holding company" or a "passive foreign investment company," as defined below) if such US Holder owns common shares representing at least 10 per cent of the voting power and value of the Company. The availability of this deduction is subject to several complex limitations which are beyond the scope of this discussion.
Foreign Tax Credit
A US Holder who pays (or has withheld from distributions) Canadian income tax with respect to the ownership of the Company's common shares may be entitled, at the option of the US Holder, to either a deduction or a tax credit for such foreign tax paid or withheld. Generally, it will be more advantageous to claim a credit because a credit reduces United States federal income tax on a dollar-for-dollar basis, while a deduction merely reduces the taxpayer's income subject to tax. This election is made on a year-by-year basis and generally applies to all foreign taxes paid by (or withheld from) the US Holder during that year. There are significant and complex limitations which apply to the credit, among which is the general limitation that the credit cannot exceed the proportionate share of the US Holder's United States income tax liability that the US Holder's foreign source income bears to his/her or its worldwide income. In the determination of the application of this limitation, the various items of income and deduction must be classified into foreign and domestic sources. Complex rules govern this classification process. In addition, this limitation is calculated separately with respect to specific classes of income such as "passive income," "high withholding tax interest," "financial services income," "shipping income," and certain other classifications of income. The availability of the foreign tax credit and the application of the limitations on the credit are fact specific, and holders and prospective holders of the Company's common shares should consult their own tax advisors regarding their own circumstances.
Disposition of Common Shares
Subject to the discussion below at "Other Considerations", a US Holder will generally recognize gain or loss upon the sale or other disposition of common shares equal to the difference, if any, between (i) the amount of cash plus the fair market value of any property received, and (ii) the shareholder's tax basis in the Company's common shares. This gain or loss will be capital gain or loss if the common shares are a capital asset in the hands of the US Holder (and if the stock is not "Section 306 Stock"), which will be a long-term capital gain or loss if the common shares of the Company are held for more than one year and which may be entitled to a preferential tax rate. Deductions for net capital losses generally may be carried over to be used in later tax years until such net capital loss is thereby exhausted. For US Holders which are corporations (other than corporations subject to Subchapter S of the Code), generally an unused net capital loss may be carried back three years from the loss year and carried forward five years from the loss year to be offset against capital gains until such net capital loss is thereby exhausted.
Other Considerations
In the following circumstances, the above sections of this discussion may not describe the United States federal income tax consequences resulting from the holding and disposition of common shares:
Foreign Personal Holding Company
If at any time during a taxable year more than 50 per cent of the total combined voting power or the total value of the Company's outstanding shares is owned, directly or indirectly (including by attribution), by five or fewer individuals who are citizens or residents of the United States and 60 per cent or more of the Company's gross income for such year (50 per cent in subsequent years) was derived from certain passive sources (e.g., dividends, interests, rents, royalties, etc.), the Company may be treated as a "foreign personal holding company." In that event, US Holders that hold common shares would be required to include in gross income for such year their allocable portions of the Company's taxable income to the extent the Company does not actually distribute such income.
Foreign Investment Company
If 50 per cent or more of the combined voting power or total value of the Company's outstanding common shares are held, directly or indirectly (including through attribution), by citizens or residents of the United States, United States domestic partnerships or corporations, or estates or trusts other than foreign estates or trusts (as defined by Code Section 7701(a) (31)), the Company is found to be engaged primarily in the business of investing, reinvesting, or trading in securities, commodities, or any interest therein, and certain other conditions are met, the Company may be treated as a "foreign investment company" as defined in Section 1246 of the Code, causing all or part of any gain realized by a US Holder selling or exchanging common shares to be treated as ordinary income rather than capital gain.
Passive Foreign Investment Company
As a foreign corporation with US Holders, the Company could potentially be treated as a passive foreign investment company ("PFIC"), as defined in Section 1297 of the Code, depending upon the percentage of the Company's income which is passive, or the percentage of the Company's assets which is producing passive income. Generally, on certain distributions and on disposition, US Holders owning common shares of a PFIC are subject to a special tax regime imposing the highest U.S. ordinary income tax rate plus an interest charge based on the value of deferral of tax for the period during which the common shares of the PFIC are owned. However, if the US Holder makes a timely election to treat a PFIC as a qualified electing fund ("QEF") with respect to such shareholder's interest therein, the above-described rules generally will not apply. Instead, the electing US Holder would include annually in gross income his/her or its pro rata share of the PFIC's ordinary earnings and net capital gain regardless of whether such income or gain was actually distributed. A US Holder making a QEF election can, however, under certain circumstances elect to defer the payment of United States federal income tax on such income inclusions subject to an interest charge on the amount of deferred taxes. Special rules apply to US Holders who own their interests in a PFIC through intermediate entities or persons. In addition, subject to certain limitations, US Holders owning (actually or constructively) marketable stock in a PFIC will be permitted to elect to mark that stock to market annually, rather than be subject to the tax regime described above. Amounts included in or deducted from income under this alternative (and actual gains and losses realized upon disposition, subject to certain limitations) will be treated as ordinary gains or losses.
The Company has not determined whether it is or has been a PFIC in earlier years. US Holders of the Company's common shares should consult with their own tax advisor concerning the possible application of the PFIC provisions in their circumstances.
Controlled Foreign Corporation
If more than 50 per cent of the voting power of all classes of stock or the total value of the stock of the Company is owned, directly or indirectly (including through attribution), by citizens or residents of the United States, United States domestic partnerships and corporations or estates or trusts other than foreign estates or trusts, each of whom own 10 per cent or more of the total combined voting power of all classes of stock of the Company ("United States Shareholder"), the Company is a "controlled foreign corporation". This classification generally results in the inclusion of certain income of a CFC in the US Shareholders' US income as a deemed dividend. In addition, under Section 1248 of the Code, gain from the sale or exchange of stock by a holder of common shares who is or was a United States Shareholder at any time during the five year period ending with the sale or exchange may be treated as ordinary dividend income.
F. Dividends and Paying Agents
Not Applicable
G. Statement by Experts
Not Applicable
H. Documents on Display
Micromem files the documents referred to herein and other information with the SEC, the Ontario Securities Commission ("OSC") and the Alberta Securities Commission ("ASC"). You may inspect and copy such material at the public reference facilities maintained by the SEC at Room 1024, 450 Fifth Street, N.W., Washington, D.C. 20549, as well as at the SEC's regional offices at 500 West Madison Street, Suite 1400, Chicago, Illinois 60661 and the Woolworth Building, 233 Broadway, New York, New York 10279. You may also obtain copies of such material from the SEC at prescribed rates by writing to the Public Reference Section of the SEC, 450 Fifth Street, N.W., Washington, D.C. 20549. Please call the SEC at 1-800-SEC-0330 for further information on the public reference rooms.
The SEC maintains an Internet website at www.sec.gov that contains reports, proxy statements, information statements and other material that are filed through the SEC's Electronic Data Gathering, Analysis and Retrieval ("EDGAR") system. Documents filed with the OSC and the ASC can be accessed through an Internet website at www.sedar.com that contains reports, proxy statements, information statements and other material that are filed through the System for Electronic Document Analysis and Retrieval ("SEDAR").
Information about Micromem is also available on its website at www.micromeminc.com. Such information on its website is not part of this Form 20-F.
I. Subsidiary Information
Not Applicable
ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES
PART II
ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES
ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS
ITEM 15. CONTROLS AND PROCEDURES
(b) Internal controls. Since the date of the evaluation described above, there have not been any significant changes in the Company's internal controls or in other factors that could significantly affect those controls.
PART III
ITEM 17. FINANCIAL STATEMENTS
Consolidated Financial Statements
(Expressed in United States dollars)
MICROMEM TECHNOLOGIES INC.
(A DEVELOPMENT STAGE COMPANY)
October 31, 2002
AUDITORS' REPORT
To the Shareholders of
Micromem Technologies Inc.
We have audited the consolidated balance sheet of Micromem Technologies Inc. (a Development Stage Company) as at October 31, 2002 and the consolidated statements of operations and deficit, cash flows and shareholders' equity for the year ended October 31, 2002 and for the cumulative period from September 3, 1997 to October 31, 2002. These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audit.
We conducted our audit in accordance with Canadian and United States generally accepted auditing standards. Those standards require that we plan and perform an audit to obtain reasonable assurance whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation.
In our opinion, these consolidated financial statements present fairly, in all material respects, the financial position of the Company as at October 31, 2002 and the results of its operations and its cash flows for the year then ended and for the cumulative period from September 3,1997 to October 31, 2002 in accordance with Canadian generally accepted accounting principles.
As discussed in note 3 to the consolidated financial statements, during 2002 the Company changed its method of accounting for patents and trademarks.
The financial statements as at October 31, 2001 and for the year then ended and for the cumulative period from September 3, 1997 to October 31, 2001 were audited by other auditors who expressed opinions without reservation on those statements in their reports dated December 20, 1999 and November 16, 2001.
Toronto, Canada,
January 27, 2003. |
/s/ Ernst & Young LLP |
Chartered Accountants |
COMMENTS BY AUDITORS FOR U.S. READERS ON CANADA-U.S. REPORTING DIFFERENCE
In the United States, reporting standards for auditors require the addition of an explanatory paragraph (following the opinion paragraph) when the financial statements are affected by conditions and events that cast substantial doubt on the Company's ability to continue as a going concern, such as those described in note 2 to the consolidated financial statements. Our report to the shareholders dated January 27, 2003 is expressed in accordance with Canadian reporting standards which do not permit a reference to such events and conditions in the auditors' report when these are adequately disclosed in the consolidated financial statements.
Toronto, Canada,
January 27, 2003. |
/s/ Ernst & Young LLP |
Chartered Accountants |
MICROMEM TECHNOLOGIES INC.
(A DEVELOPMENT STAGE COMPANY)
Consolidated Balance Sheet
(Expressed in United States dollars)
[see note 2 –going concern]As at October 31
|
|
2002 |
|
|
2001 |
|
|
|
|
|
|
|
|
Assets |
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
Cash and cash equivalents |
$ |
983,939 |
|
$ |
3,556,517 |
|
Deposits and other receivables (note 5) |
|
193,131 |
|
|
228,143 |
|
|
|
1,177,070 |
|
|
3,784,660 |
|
Capital assets (note 6) |
|
98,654 |
|
|
336,839 |
|
Patents and trademarks (note 7) |
|
307,698 |
|
|
332,971 |
|
Royalty rights (note 4 and 11) |
|
– |
|
|
10,000,000 |
|
|
$ |
1,583,422 |
|
$ |
14,454,470 |
|
|
|
|
|
|
|
|
Liabilities and Shareholders' Equity |
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
Accounts payable and accrued liabilities (note 8) |
$ |
191,519 |
|
$ |
329,552 |
|
|
|
|
|
|
|
|
Shareholders' equity: |
|
|
|
|
|
|
Share capital (note 9): |
|
|
|
|
|
|
Authorized: |
|
|
|
|
|
|
2,000,000 special preference shares, redeemable, voting |
|
|
|
|
|
|
Unlimited common shares without par value |
|
|
|
|
|
|
Issued and outstanding: |
|
|
|
|
|
|
46,700,937 common shares (2001 - 45,935,349) |
|
31,073,787 |
|
|
29,642,242 |
|
Contributed surplus (note 10) |
|
578,891 |
|
|
2,010,436 |
|
Deficit accumulated during the development stage |
|
(30,260,775) |
|
(17,527,760) |
||
|
|
1,391,903 |
|
|
14,124,918 |
|
Commitments and contingencies (notes 4, 14, 15 and 18) |
|
|
|
|
|
|
|
$ |
1,583,422 |
|
$ |
14,454,470 |
|
See accompanying notes to consolidated financial statements.
On behalf of the Board:
"Joseph Fuda" (signed) |
|
Director |
|
|
|
"Charles Harnick" (signed) |
|
Director |
MICROMEM TECHNOLOGIES INC.
(A DEVELOPMENT STAGE COMPANY)
Consolidated Statements of Operations and Deficit
(Expressed in United States dollars)
Years ended October 31
Period from |
|||||||||
September 3, |
|||||||||
1997 to |
|||||||||
October 31, |
|||||||||
2002 |
2001 |
2000 |
2002 |
||||||
Revenue: | |||||||||
Interest and other income |
$ |
165,892 |
$ |
185,590 |
$ |
140,231 |
$ |
495,587 |
|
Costs and expenses (income): | |||||||||
Administration |
347,256 |
403,178 |
610,173 |
1,822,982 |
|||||
Professional fees |
262,927 |
473,653 |
1,086,839 |
2,394,373 |
|||||
Wages and salaries (note 9(b)) |
562,532 |
1,372,375 |
3,688,299 |
9,225,174 |
|||||
Research and development |
1,601,624 |
2,212,679 |
1,205,777 |
5,525,368 |
|||||
Travel and entertainment |
73,385 |
205,757 |
255,385 |
972,458 |
|||||
Operating leases |
– |
– |
81,689 |
109,412 |
|||||
Loss on sale of investment |
– |
– |
– |
54,606 |
|||||
Write-down of investment |
– |
– |
– |
61,020 |
|||||
Write-down of royalty rights (note 11) |
10,000,000 |
– |
– |
10,000,000 |
|||||
Amortization of patents and trademarks |
31,338 |
– |
– |
31,338 |
|||||
Amortization of capital assets |
40,635 |
65,298 |
180,928 |
299,210 |
|||||
Fees to related parties (note 13(b)) |
– |
– |
186,000 |
186,000 |
|||||
Interest expense |
– |
– |
71,781 |
75,027 |
|||||
Unrealized foreign exchange loss (gain) |
14,747 |
(7,009 |
) |
7,716 |
(9,353 |
) | |||
12,934,444 |
4,725,931 |
7,374,587 |
30,747,615 |
||||||
Loss before other income and income taxes |
12,768,552 |
4,540,341 |
7,234,356 |
30,252,028 |
|||||
Other income |
– |
(10,930 |
) |
– |
(10,930 |
) | |||
Loss before income taxes |
12,768,552 |
4,529,411 |
7,234,356 |
30,241,098 |
|||||
Provision for (recovery of) income taxes | |||||||||
Current (note 12) |
(35,537) |
30,214 |
25,000 |
19,677 |
|||||
Net loss for the period |
12,733,015 |
4,559,625 |
7,259,356 |
30,260,775 |
|||||
Deficit accumulated during the | |||||||||
development stage, beginning of period |
17,527,760 |
12,968,135 |
5,708,779 |
– |
|||||
Deficit accumulated during the | |||||||||
development stage, end of period |
$ |
30,260,775 |
$ |
17,527,760 |
$ |
12,968,135 |
$ |
30,260,775 |
|
Loss per share - basic and diluted |
$ |
0.27 |
$ |
0.10 |
$ |
0.19 |
$ |
0.65 |
|
Weighted average number of basic and | |||||||||
diluted shares outstanding |
46,396,799 |
44,163,669 |
38,763,920 |
46,396,799 |
See accompanying notes to consolidated financial statements.
MICROMEM TECHNOLOGIES INC.
(A DEVELOPMENT STAGE COMPANY)
Consolidated Statement of Cash Flows
(Expressed in United States dollars)
Years ended October 31
|
|
|
|
|
|
|
|
Period from |
|
|
|
|
|
|
|
|
|
|
September 3, |
|
|
|
|
|
|
|
|
|
|
1997 to |
|
|
|
|
|
|
|
|
|
|
October 31, |
|
|
|
|
2002 |
|
2001 |
|
2000 |
|
2002 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
|
|
Net loss for the period |
$ |
(12,733,015 |
) |
$(4,559,625 |
) |
(7,259,356 |
) |
$(30,260,775 |
) |
|
Adjustments to reconcile loss for the period to
|
|
|
|
|
|
|
|
|
|
|
Loss (gain) on sale of investment |
|
– |
|
(4,796 |
) |
– |
|
49,810 |
|
|
Write-down of investment |
|
– |
|
– |
|
– |
|
61,020 |
|
|
Loss (gain) on sale of assets |
|
13,292 |
|
(6,134 |
) |
– |
|
7,158 |
|
|
Write-down of royalty rights |
|
10,000,000 |
|
– |
|
– |
|
10,000,000 |
|
|
Amortization of patents |
|
|
|
|
|
|
|
|
|
|
and trademarks |
|
31,338 |
|
– |
|
– |
|
31,338 |
|
|
Amortization of capital assets |
|
170,710 |
|
200,519 |
|
230,927 |
|
484,430 |
|
|
Share compensation expense |
|
– |
|
754,125 |
|
3,247,721 |
|
7,285,696 |
|
|
Non-cash wages and salaries |
|
– |
|
34,000 |
|
– |
|
34,000 |
|
|
Change in non-cash working capital items, |
|
|
|
|
|
|
|
|
|
|
net of effects from reverse takeover: |
|
|
|
|
|
|
|
|
|
|
Decrease (increase) in deposits |
|
|
|
|
|
|
|
|
|
|
and other receivables |
|
35,012 |
|
64,142 |
|
(276,565 |
) |
(184,534 |
) |
|
Increase (decrease) in accounts |
|
|
|
|
|
|
|
|
|
|
payable and accrued liabilities |
|
(138,033 |
) |
(139,199 |
) |
71,579 |
|
85,475 |
|
|
Net cash used in operating activities |
|
(2,620,696 |
) |
(3,656,968 |
) |
(3,985,694 |
) |
(12,406,382 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
|
|
Sale of available-for-sale investment |
|
– |
|
27,000 |
|
– |
|
260,641 |
|
|
Capital assets, net |
|
54,183 |
|
(150,099 |
) |
(556,955 |
) |
(590,242 |
) |
|
Patents and trademarks |
|
(6,065 |
) |
(127,652 |
) |
(205,219 |
) |
(339,036 |
) |
|
Royalty rights |
|
– |
|
(2,000,000 |
) |
– |
|
(2,000,000 |
) |
|
Advance to related party |
|
– |
|
– |
|
362,046 |
|
– |
|
|
Net cash provided by (used in) |
|
|
|
|
|
|
|
|
|
|
investing activities |
|
48,118 |
|
(2,250,751 |
) |
(400,128 |
) |
(2,668,637 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
|
|
Issue of common shares |
|
– |
|
8,221,379 |
|
5,574,716 |
|
15,478,233 |
|
|
Net proceeds from shareholder loan |
|
– |
|
– |
|
– |
|
544,891 |
|
|
Loan proceeds from Avanticorp |
|
– |
|
– |
|
– |
|
112,031 |
|
|
Rights issue costs |
|
– |
|
– |
|
(76,197 |
) |
(76,197 |
) |
|
Net cash provided by financing activities |
|
– |
|
8,221,379 |
|
5,498,519 |
|
16,058,958 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Increase (decrease) in cash |
|
|
|
|
|
|
|
|
|
|
and cash equivalents |
|
(2,572,578 |
) |
2,313,660 |
|
1,112,697 |
|
983,939 |
|
|
Cash and cash equivalents, |
|
|
|
|
|
|
|
|
|
|
beginning of period |
|
3,556,517 |
|
1,242,857 |
|
130,160 |
|
– |
|
|
Cash and cash equivalents, |
|
|
|
|
|
|
|
|
|
|
end of period |
$ |
983,939 |
$ |
3,556,517 |
$ |
1,242,857 |
$ |
983,939 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental cash flow information: |
|
|
|
|
|
|
|
|
|
|
Interest paid |
$ |
1,960 |
$ |
– |
$ |
71,781 |
$ |
76,987 |
|
|
Income taxes paid |
|
11,508 |
|
46,021 |
|
9,193 |
|
66,722 |
|
MICROMEM TECHNOLOGIES INC.
(A DEVELOPMENT STAGE COMPANY)
Consolidated Statement of Cash Flows (continued)
(Expressed in United States dollars)
Years ended October 31, 2002
Supplemental information on non-cash investing activities:
The following transactions are considered to be non-cash transactions and have been excluded from the consolidated statement of cash flows:
During fiscal 2001, the Company issued 2,007,831 common shares, being the equivalent of $8,000,000, in respect of closing of the asset purchase agreement as described in note 4.
During fiscal 2001, common shares having a value $1,647,703 (2000 - $4,206,447) were issued pursuant to compensation agreements.
See accompanying notes to consolidated financial statements.
Consolidated Statement of
Shareholders' Equity
(Expressed in United States
dollars)
|
|
|
|
|
|
|
|
Deficit |
||
|
|
|
|
|
|
|
|
|
Accumulated |
|
|
|
|
|
|
|
|
Deferred |
|
during |
|
|
Number of |
|
Share |
|
Contributed |
|
share |
|
development |
|
|
shares |
|
Capital |
|
surplus |
|
compensation |
|
stage |
|
|
|
|
|
|
|
|
|
|
|
|
Micromem share capital, October 31, 1998 |
3,490,643 |
$ |
– |
$ |
– |
$ |
– |
$ |
– |
|
Exercise of director’s stock options |
490,000 |
|
– |
|
– |
|
– |
|
– |
|
Pageant share capital, October 31, 1998 |
– |
$ |
1 |
$ |
– |
$ |
– |
$ |
– |
|
Net loss for the year |
– |
|
– |
|
– |
|
– |
|
(500,992 |
) |
Common shares of Pageant, December 4, 1998 |
– |
|
4,999 |
|
– |
|
– |
|
– |
|
Assigned fair value of net assets (note 3(b)(iv)) |
32,000,000 |
|
549,140 |
|
– |
|
– |
|
– |
|
Micromem share capital, September 11, 1999 |
35,980,643 |
|
554,140 |
|
– |
|
– |
|
(500,992 |
) |
Exercise of common share purchase warrants |
|
|
|
|
|
|
|
|
– |
|
for cash |
120,676 |
|
164,053 |
|
– |
|
– |
|
– |
|
Private placement of common shares for |
|
|
|
|
|
|
|
|
|
|
cash, May 17, 1999 |
350,000 |
|
1,050,000 |
|
– |
|
– |
|
– |
|
Shareholder loan forgiven (note 10) |
– |
|
– |
|
544,891 |
|
– |
|
– |
|
Exercise of stock options for cash |
100,000 |
|
300,000 |
|
– |
|
– |
|
– |
|
Net loss for the year |
– |
|
– |
|
– |
|
– |
|
(5,207,787 |
) |
Balance, October 31, 1999 |
36,551,319 |
|
2,068,193 |
|
544,891 |
|
– |
|
(5,708,779 |
) |
Exercise of common share purchase warrants |
|
|
|
|
|
|
|
|
|
|
for cash |
182,087 |
|
274,717 |
|
|
|
– |
|
– |
|
Exercise of stock options for cash |
100,000 |
|
300,000 |
|
– |
|
|
|
– |
|
Deferred share compensation (note 13(a)) |
– |
|
– |
|
2,711,881 |
|
(453,219 |
) |
– |
|
Private placement of common shares for |
|
|
|
|
|
|
|
|
|
|
cash, February 10, 2000 |
2,000,000 |
|
5,000,000 |
|
|
|
|
|
|
|
Common shares issued pursuant to |
|
|
|
|
|
|
|
|
|
|
Compensation agreements, March 15, 2000 |
901,110 |
|
4,206,447 |
|
|
|
– |
|
|
|
Net loss for the year |
– |
|
|
|
|
|
|
|
(7259,356 |
) |
Balance, October 31, 2000 |
39,734,516 |
|
11,849,357 |
|
3,256,772 |
|
(453,219 |
) |
(12,968,135 |
) |
Exercise of common share purchase warrants |
|
|
|
|
||||||
for cash |
362,450 |
|
|
|
554,655 |
|
|
|
|
|
Common shares issued under the rights |
||||||||||
offering, November 20, 2000 |
304,674 |
|
1,119,058 |
|
– |
|
– |
|
– |
|
Exercise of stock options for cash |
800,000 |
|
2,400,000 |
|
– |
|
– |
|
– |
|
Deferred share compensation (note 13(a)) |
– |
|
|
|
(453,219 |
) |
453,219 |
|
|
|
Stock-based compensation (note 9 (b)) |
– |
|
|
|
34,000 |
|
|
|
|
|
Exercise of director’s stock options |
|
|
|
|
||||||
for cash, January 17, 2001 |
714,686 |
|
71,469 |
|
– |
|
– |
|
– |
|
Common shares issued pursuant to compensatory |
|
|
|
|
– |
|
– |
|
– |
|
stock options, at January 17, 2001 (note 13 (a)) |
– |
|
1,581,242 |
|
(1,581,242) |
|
|
|
|
|
Adjustment-share compensation |
|
|
|
|
|
|
|
|
||
Expenses (note 13 (a)) |
– |
|
– |
|
(677,420) |
|
– |
|
– |
|
Common shares issued pursuant to compensation |
|
|
|
|
|
|
|
|
|
|
agreement, January 23, 2001 (note 13 (a)) |
11,192 |
|
66,461 |
|
– |
|
– |
|
– |
|
Private placement of common shares for |
|
|
|
|
|
|
|
|
|
|
cash, March 13, 2001 |
2,000,000 |
|
4,000,000 |
|
– |
|
– |
|
– |
|
Common shares issued under the asset purchase |
|
|
|
|
|
|
|
|
|
|
agreement to Estancia Limited, March 14, 2001 |
2,007,831 |
|
8,000,000 |
|
– |
|
1,431,545 |
|
– |
|
Compensation shares due but not issued (note 13 (a)) |
– |
|
– |
|
– |
|
– |
|
– |
|
Net loss for the year |
|
|
|
|
|
|
|
|
(4,559,625 |
) |
Balance, October 31, 2001 |
45,935,349 |
|
29,642,242 |
|
2,010,436 |
|
|
|
(17,527,760 |
) |
Shares issued pursuant to compensatory |
|
|
|
|
|
|
|
|
|
|
agreement, March 26, 2002 (note 13 (a)) |
765,588 |
|
1,431,545 |
|
(1,431,545 |
) |
|
|
|
|
Net loss for the year |
– |
|
– |
|
– |
|
|
|
(12,733,015 |
) |
Balance, October 31, 2002 |
46,700,937 |
$ |
31,073,787 |
|
578,891 |
|
|
|
-30,260,775 |
|
MICROMEM TECHNOLOGIES INC.
(A DEVELOPMENT STAGE COMPANY)
Notes to Consolidated Financial Statements
(Expressed in United States dollars)
October 31, 2002
|
1. Nature of Business:
Micromem Technologies Inc. ("Micromem" or the "Company") is a corporation incorporated under the laws of the Province of Ontario, Canada. By Articles of Amendment dated January 14, 1999, the Company changed its name from Avanticorp International Inc. to Micromem Technologies Inc. On January 11, 1999, the Company acquired all the outstanding shares of Pageant Technologies Inc. ("Pageant"), a company subsisting under the laws of Barbados. This acquisition, as described in note 3(b), was recorded as a reverse takeover under Canadian generally accepted accounting principles (“Canadian GAAP”).
The Company currently operates in a single segment as a developer of non-volatile magnetic memory technology. To October 31, 2002, the Company has not generated significant revenue and is devoting substantially all its efforts to the development of its technologies. Accordingly, for financial reporting purposes, the Company is a development stage enterprise and, through its wholly-owned subsidiaries, is engaged in the development and testing of its non-volatile memory technologies.
2. Going Concern:
These consolidated financial statements have been prepared on the "going concern" basis, which presumes that the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future.
The Company has incurred substantial losses in its development stage and is still in the development stage. It will be necessary to raise additional funds for the continuing development, testing and commercial exploitation of its technologies. The sources of these funds have not yet been identified and there can be no certainty that sources will be available in the future.
The Company's ability to continue as a going concern is dependent upon completing the development of its technology for a particular application, achieving profitable operations, obtaining additional financing, and successfully bringing its technologies to the market. The outcome of these matters cannot be predicted at this time. The consolidated financial statements have been prepared on a going concern basis and do not include any adjustments to the amounts and classifications of the assets and liabilities that might be necessary should the Company be unable to continue in business.
MICROMEM TECHNOLOGIES INC.
(A DEVELOPMENT STAGE COMPANY)
Notes to Consolidated Financial Statements
(Expressed in United States dollars)
October 31, 20023. Summary of significant accounting policies:
These consolidated financial statements have been prepared in accordance with Canadian GAAP and are stated in United States dollars. These principles are also in conformity in all material respects with United States generally accepted accounting principles ["U.S. GAAP"] except as described in note 17 to the consolidated financial statements. The most significant accounting policies are as follows:
(a) Principles of consolidation
These consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Memtech International Inc., Memtech International (USA) Inc., Micromem Technologies B.V., Micromem Technologies S.p.A., Pageant Technologies Inc. and Pageant Technologies (U.S.A.) Inc. All significant intercompany balances and transactions have been eliminated upon consolidation.
(b) Basis of presentation:
On January 11, 1999, the Company issued 32,000,000 common shares and 1,000,000 warrants to acquire all of the issued and outstanding shares of Pageant. On that date, the total number of the Company shares outstanding was 3,980,643 shares. As a result of this transaction, the shareholders of Pageant owned 88.9% of the outstanding common shares of the Company and, accordingly, the purchase of Pageant was accounted for as a reverse takeover transaction.
Application of reverse takeover accounting results in the following:
(i) the consolidated financial statements of the combined entity are issued under the name of the legal parent, Micromem, but are considered a continuation of the financial statements of Pageant, the legal subsidiary;
(ii) as Pageant is deemed to be the acquirer for accounting purposes, its assets and liabilities are included in the consolidated financial statements at their historical carrying values;
(iii) the comparative financial statements for the period from September 3, 1997 to October 31, 1998 are those of Pageant;
MICROMEM TECHNOLOGIES INC.
(A DEVELOPMENT STAGE COMPANY)
Notes to Consolidated Financial Statements
(Expressed in United States dollars)
October 31, 2002
|
3. Summary of significant accounting policies (continued):
(iv) control of the assets and operations of the Company is deemed to be acquired by Pageant effective January 11, 1999. For purposes of this transaction, the deemed consideration is $549,140 ascribed to the net assets of the Company outstanding immediately prior to the business combination; and
(v) Pageant became a wholly-owned subsidiary of the Company. For accounting purposes, at January 11, 1999, the outstanding shares of the Company, the continuing consolidated entity, consisted of the number of Micromem Shares issued to that date with an assigned value equal to the share capital of the continuing consolidated entity at that date as computed below.
The transaction was accounted for by the purchase method with the results of operations included in the financial statements from the date of acquisition. Details of the Company’s net assets acquired and the assigned fair values of net assets at acquisition are as follows:
|
|
|
|
|
|
|
|
Cash |
$ |
168,084 |
|
Non-cash current assets |
|
115,629 |
|
Investments |
|
371,471 |
|
|
|
655,184 |
|
Less current liabilities |
|
106,044 |
|
Assigned fair value of net assets |
$ |
549,140 |
(c) Use of estimates:
The preparation of consolidated financial statements in conformity with Canadian GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
(d) Cash and cash equivalents:
Cash and cash equivalents consist of all bank accounts and all highly liquid investments with original maturities of three months or less at the date of purchase.
MICROMEM TECHNOLOGIES INC.
(A DEVELOPMENT STAGE COMPANY)
Notes to Consolidated Financial Statements
(Expressed in United States dollars)
October 31, 2002
|
3. Summary of significant accounting policies (continued):
(e) Capital assets:
Capital assets are recorded at cost less accumulated amortization. Amortization is provided on capital assets on a straight-line basis for a period of up to three years. Capital assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. When circumstances dictate, an impairment loss is calculated as equal to the excess of the carrying value of the assets over their undiscounted estimated future net cash flow.
(f) Patents and trademarks:
Effective November 1, 2001, the Company changed its accounting policy for patents and trademarks to be recorded at cost less accumulated amortization which is provided on a straight-line basis over ten years. In prior years the Company accounted for its patents and trademarks at cost and amortization was to commence on an appropriate basis to charge off the cost over the future benefit, not exceeding the legal life, when sales commence. There was no material impact on prior years consolidated financial statements and accordingly, the comparative consolidated financial statements have not been restated.
For the year ended October 31, 2002, the change in accounting policy resulted in an increase in amortization expense and net loss by $31,338 and there was no material impact on net loss per share.
Patents and trademarks are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. When circumstances dictate, an impairment loss is calculated as equal to the excess of the carrying value of the assets over their undiscounted estimated future net cash flow.
(g) Research and development expenses:
Research costs are expensed in the period incurred. Development expenses are expensed as incurred unless they meet the criteria for deferral and amortization under Canadian GAAP. The Company has determined that no development costs have met these criteria at the financial reporting date.
MICROMEM TECHNOLOGIES INC.
(A DEVELOPMENT STAGE COMPANY)
Notes to Consolidated Financial Statements
(Expressed in United States dollars)
October 31, 2002
|
3. Summary of significant accounting policies (continued):
(h) Stock-based compensation:
The Company has a stock-based compensation plan, which is described in note 9. Stock-based compensation is recognized by the intrinsic value method, whereby compensation is recorded to the extent that the exercise price is not based on the market value of the Company’s common shares at the date of grant. Any compensatory benefit recorded is recognized initially as deferred compensation in the consolidated statements of shareholders’ equity, and then charged against income over the contractual or vesting period.
(i) Income taxes:
The Company accounts for income taxes by the asset and liability method. Under the asset and liability method, future tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Future tax assets and liabilities are measured using substantively enacted tax rates and laws that are expected to apply when the asset is realized or the liability settled. To the extent that it is not considered to be more likely than not that a future income tax asset will be realized, a valuation allowance is provided.
(j) Foreign currency translation:
The functional currency of the Company is the United States dollar. The Company's wholly-owned subsidiaries are integrated foreign operations and therefore, the Company uses the temporal method whereby monetary assets and liabilities are translated into Canadian dollars using the rate of exchange at the consolidated balance sheet dates. Non-monetary assets and liabilities are translated at historical rates. Revenue and expenses are translated at rates of exchange prevailing at the transaction dates. Gains or losses resulting from translation are included in the determination of net loss for the period.
MICROMEM TECHNOLOGIES INC.
(A DEVELOPMENT STAGE COMPANY)
Notes to Consolidated Financial Statements
(Expressed in United States dollars)
October 31, 2002
|
3. Summary of significant accounting policies (continued):
The Company's monetary assets and liabilities denominated in foreign currencies are translated into United States dollars at the exchange rate in effect at the consolidated balance sheet dates. Non-monetary assets and liabilities that are denominated in currencies other than United States dollars are translated into United States dollars using the historical rate of exchange in effect on the date the transaction occurred. Revenue and expense items are translated at the exchange rate in effect at the date of the transaction. Resulting exchange gains or losses are included in net loss for the period.
MICROMEM TECHNOLOGIES INC.
(A DEVELOPMENT STAGE COMPANY)
Notes to Consolidated Financial Statements
(Expressed in United States dollars)
October 31, 2002
|
4. Acquisition of royalty rights and remaining interest in technology from Estancia Limited
On December 9, 2000, the Company and its subsidiary, Pageant, entered into an Asset Purchase Agreement (the “Agreement”) with Estancia Limited (“Estancia”) and Richard Lienau (“Lienau”) to purchase the remaining 50% interests in the patents which the Company did not own, and a 40% gross profit royalty (“Estancia Royalty”), in respect of certain ferromagnetic memory technology known as VEMRAM (previously known as MAGRAM) and covered by U.S. Patent #5,295,097 and the related patent applications (the “VEMRAM Patents”) described in the agreement and all rights (the “VEMRAM Technology”) held by Estancia and Lienau under the Joint Ownership and Licensing Agreement dated September 17, 1997 among Estancia, Lienau and Pageant. Under the terms of the Agreement:
(i) the Company would be required to pay a maximum purchase price of $50,000,000 to Estancia as follows:
(a) $10,000,000 was paid on closing (after receipt of regulatory approvals), in the form of $8,000,000 in common shares of the Company (“Micromem Shares”) (based on the close price on the closing date) and $2,000,000 in cash;
(b) $20,000,000 if and when either (i) certification is received from Honeywell Federal Manufacturing & Technologies (“Honeywell”) and that fully integrated, randomly addressable memory matrices of the Technology have met certain stipulated performance standards, or (ii) the Company or any of its affiliates executes a definitive agreement for the sale or licensing of the Technology to an arm’s length third party for any commercial purposes other than testing or evaluation of the Technology; payable in the form of cash and Micromem Shares to be determined by Pageant provided that a minimum of 50% of the $20,000,000 shall be paid in Micromem Shares valued at the close of trading on the date of receipt of such certification, sale or licensing; and
(c) $20,000,000 if and when the Company or any of its affiliates executes a definitive agreement for the sale or licensing with respect to any technology (including the Technology) owned by the Company to an arm’s length third party for any commercial purposes other than testing or evaluation of the technology, payable in the form of cash and Micromem Shares to be determined by Pageant provided that a minimum of 50% of the $20,000,000 shall be paid in Micromem Shares valued at the close of trading on the date of execution of such sale or licensing.
MICROMEM TECHNOLOGIES INC.
(A DEVELOPMENT STAGE COMPANY)
Notes to Consolidated Financial Statements
(Expressed in United States dollars)
October 31, 2002
|
4. Acquisition of royalty rights and remaining interest in technology from Estancia Limited
Limited (continued):
(ii) In the event that the amounts contemplated by 4(i)(b) and/or (c) above are not payable to Estancia by the third anniversary date of the closing date and provided that Estancia and Lienau are not in material breach of the terms and conditions of this agreement, Micromem shall be deemed to have conveyed and agreed, as of such date, and there shall automatically revert, without further action and notwithstanding any recordation requirements, to Estancia:
(a) an undivided interest equal to 50% of the percentage determined by dividing (i) the remaining unpaid amount due pursuant to 4(i)(b) and/or (c) above by (ii) $50,000,000 (the “Final Payment Percentage Balance”) in the VEMRAM Patents; and
(b) an undivided interest (“Royalty”) equal to 40% of the Final Payment Percentage Balance in:
(1) the gross profit, less expenses agreed to by the parties, for each license of the VEMRAM Patents sold or otherwise transferred by Pageant; and
(2) the amount of all royalties received by Pageant as a result of the license or sale of the VEMRAM Patents less reasonable expenses directly related to obtaining of said royalties.
Estancia has a first charge security interest against the assets of Pageant’s wholly-owned subsidiary which holds a 40% interest in the VEMRAM Patents and a 32% interest in the Royalty.
The Company paid $2,000,000 in cash and issued 2,007,831 shares, being the equivalent of $8,000,000, the first installment payable under the terms described above, on approval by its shareholders in the annual shareholder meeting held on March 14, 2001. The amount of $10,000,000 paid in the form of cash and shares, has been recorded as royalty rights in these consolidated financial statements. During fiscal 2002, the amount was written-down to nil (note 11).
The consideration noted in note 4(i)(b) and (c) above will be recorded when the milestones triggering the Company’s obligations to pay said consideration, as described in the agreement, have been achieved.
MICROMEM TECHNOLOGIES INC.
(A DEVELOPMENT STAGE COMPANY)
Notes to Consolidated Financial Statements
(Expressed in United States dollars)
October 31, 2002
|
5. Deposits and other receivables:
2002 2001 Sales tax recoverable $
11,048 $ 7,613 Deposits (notes 14(a)) 131,305 161,138 Other receivables $ 50,778 59,392 $ 193,131 $ 228,143
6. Capital assets:
2001 Additions Disposal 2002 Cost:
$
48,968
$
–
$
31,536
$
17,432
Furniture and fixtures 508,109 28,580 329,536 207,153 Computers and equipment $
557,077 $
28,580 $
361,072 $
224,585
2002 2001 Net book value: $ 3,831 $ 31,945 Furniture and fixtures 94,823 94,823 Computers and equipment $ 98,654 $ 336,839
Included in research and development expenses is $130,075 (2001 - $135,221, 2000 - $49,999) of amortization expense. Amortization expense recognized on computers and equipment for the year ended October 31, 2002 includes an impairment loss of nil (2001 - nil, 2000 - $140,000).
MICROMEM TECHNOLOGIES INC.
(A DEVELOPMENT STAGE COMPANY)
Notes to Consolidated Financial Statements
(Expressed in United States dollars)
October 31, 2002
|
7. Patents and trademarks:
|
|
|
|
Accumulated |
|
net book |
As at October 31, 2002 |
|
cost |
|
amortization |
|
value |
|
|
|
|
|
|
|
Patents |
$ |
292,939 |
$ |
26,918 |
$ |
266,021 |
Trademarks |
|
46,097 |
|
4,420 |
|
41,677 |
|
$ |
339,036 |
$ |
31,338 |
$ |
307,698 |
|
|
|
|
Accumulated |
|
net book |
As at October 31, 2001 |
|
cost |
|
amortization |
|
value |
|
|
|
|
|
|
|
Patents |
$ |
286,014 |
$ |
– |
$ |
286,014 |
Trademarks |
|
46,957 |
|
– |
|
46,957 |
|
$ |
332,971 |
$ |
– |
$ |
332,971 |
The Company, through its subsidiaries, has other pending patent applications relating to its memory technologies and the costs relating to legal and filing fees are capitalized as patents. The Company has applied to register the trademarks MAGRAM™, VEMRAM™, Micromem™ and HEMRAM™ in a number of countries.
8. Accounts payable and accrued liabilities:
2002 | 2001 | |||
Trade and other payables | $ | 191,519 | $ | 325,359 |
Payroll | $ | – | $ | 4,193 |
MICROMEM TECHNOLOGIES INC.
(A DEVELOPMENT STAGE COMPANY)
Notes to Consolidated Financial Statements
(Expressed in United States dollars)
October 31, 2002
|
9. Share capital:
(a) Authorized:
2,000,000 special preference shares, redeemable, voting. Unlimited common shares without par value.
(b) Stock option plans:
The Company has a fixed stock option plan. Under the Company’s Stock Option Plan (the “Plan”), the Company may grant options for up to 13,000,000 shares of common stock to directors, officers, employees or consultants of the Company and its subsidiaries. Under the Plan, the exercise price of each option is equal to or greater than the market price of the Company's shares on the date of grant unless otherwise permitted by applicable securities regulations. An option's maximum term under the Plan is 10 years. Prior to fiscal 1999, the Company did not have a stock option plan.
A summary of the status of the Company's fixed stock option plan as at October 31, 2002, 2001 and 2000 and changes during the years ending on those dates is as follows:
2002
2001
2000
Weighted
Weighted
Weighted
average
average
average
Shares in
exercise
Shares in
exercise
Shares in
exercise
thousands
price
thousands
price
thousands
price
Outstanding, beginning of year
$
7,370
$
4.80
3,550
$
6.00
900
$
3.00
Granted
–
–
6,560
4.19
2,750
6.87
Forfeited/expired
(1,990
6.23
(1,940
)
5.65
–
–
Exercised
–
–
-800
3.00
(100
)
3.00
Outstanding, end of year
$
5,380
$
4.27
7,370
$
4.8
3,550
$
6.00
Options exercisable at year end
2,995
3,130
2,225
Weighted average fair value of
options granted during the year
–
$
1.84
$
3.89
MICROMEM TECHNOLOGIES INC.
(A DEVELOPMENT STAGE COMPANY)
Notes to Consolidated Financial Statements
(Expressed in United States dollars)
October 31, 2002
|
9. Share capital (continued):
The following table summarizes information about fixed stock options outstanding as at October 31, 2002:
Options outstanding
Options exercisable
Weighted
average
Weighted
Weighted
Actual
remaining
average
average
exercise
Number
contractual
exercise
Number
exercise
price
outstanding
life (in years)
price
exercisable
price
$
2.20
60,000
0.42
$
2.20
60,000
$
2.20
3.125
1,000,000
0.25
3.125
1,000,000
3.125
3.1875
500,000
0.31
3.1875
500,000
3.1875
3.19
2,285,000
3.04
3.19
–
3.19
7.06
1,535,000
2.34
7.06
1,435,000
7.06
5,380,000
2,995,000
Included in wages and salaries is an amount of nil (2001 - $34,000, 2000 - nil) related to stock-based compensation on options granted to a consultant of the Company.
(c) Loss per share
Basic loss per share is calculated by dividing net loss [the numerator] by the weighted average number of common shares outstanding [the denominator] during the period. Diluted loss per share reflects the dilution that would occur if outstanding stock options and share purchase warrants were exercised or converted into common shares using the treasury stock method and are calculated by dividing net loss applicable to common shares by the sum of the weighted average number of common shares outstanding and all additional common shares that would have been outstanding if potentially dilutive common shares had been issued.
The inclusion of the Company's stock options and share purchase warrants in the computation of diluted loss per share would have an anti-dilutive effect on loss per share and are therefore excluded from the computation. Consequently, there is no difference between basic loss per share and diluted loss per share.
MICROMEM TECHNOLOGIES INC.
(A DEVELOPMENT STAGE COMPANY)
Notes to Consolidated Financial Statements
(Expressed in United States dollars)
October 31, 2002
|
10. Contributed surplus:
Ataraxia Corp., the former parent company of Pageant, forgave $544,891 of indebtedness it was owed during fiscal year 1999. This forgiven debt was treated as contributed surplus, a separate component of shareholders' deficiency, as this balance was between related parties.
11. Restructuring and write-down of royalty rights:
On July 29, 2002, the Company restructured its operations by closing its research and development facility and adopted a plan to focus its current resources to outsource its research and development activities as described in note 14 (a). No major costs were associated with this restructuring. The Company is still at the research and development stage. The development of this technology is contingent upon raising additional funds. Currently there is no assurance that Micromem will be able to raise such funds.
As a result of the restructuring, the Company determined that there was significant uncertainty that any amounts that would have been payable to Estancia in the foreseeable future in respect of the Estancia Royalty (that was purchased by Pageant under the Asset Purchase Agreement). Accordingly the Estancia Royalty rights acquired in the amount of $10,000,000 were written off in the statements of operations and deficit.
12. Income taxes:
The Company has non-capital losses of approximately $4,905,000 available to reduce future taxable income, the benefit of which has not been recognized in these accounts. The tax losses expire as follows:
Other
2002
Canada
foreign
Total
2006
$
268,000
$
–
$
268,000
2007
1,632,000
108,000
1,740,000
2008
1,363,000
–
1,363,000
2009
1,063,000
–
1,063,000
2010
–
265,000
265,000
2011
–
206,000
206,000
Total assets
$
4,326,000
$
579,000
$
4,905,000
MICROMEM TECHNOLOGIES INC.
(A DEVELOPMENT STAGE COMPANY)
Notes to Consolidated Financial Statements
(Expressed in United States dollars)
October 31, 2002
|
12. Income taxes (continued):
Future income taxes reflect the net tax effect of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company's future tax assets and liabilities as at October 31 are as follows:
2002
Unused capital losses
$
14,563
Unused non-capital losses
1,348,467
Alternative minimum tax credit
142,091
Research and development credit
118,720
Financing charges
30,020
Tax basis of capital assets in excess of carrying value
58,084
Total future tax assets
$
1,711,945
Valuation allowance
(1,711,945
)
Net future tax asset
$
–
2001
Unused capital losses
$
370,443
Unused non-capital losses
1,568.130
Alternative minimum tax credit
119,475
Research and development credit
98,867
Financing charges
48,161
Total future tax assets
$
2,205,076
Valuation allowance
(2,205,076
)
Net future tax asset
$
–
MICROMEM TECHNOLOGIES INC.
(A DEVELOPMENT STAGE COMPANY)
Notes to Consolidated Financial Statements
(Expressed in United States dollars)
October 31, 2002
|
12. Income taxes (continued):
The reconciliation of income tax attributable to continuing operations computed at the statutory tax rates to income tax expense is as follows:
2002
Consolidated accounting loss before income taxes
$
(12,768,552
)
Statutory rates
39
%
Expected income tax recovery
(4,979,735
)
Permanent differences, write-down of royalty rights
3,650,000
Tax benefit not recognized
1,294,198
$
(35,537
)
13. Management compensation and related party transactions:
[a] The Company has previously entered into the following stock based management compensation arrangements:
(i) Effective November 1, 2001, the Company has terminated Chairman's compensation agreement described in note 13(a)(ii) below and the Chairman’s compensation was reduced to $1.00 per year. (ii) On January 1, 2001, the Company entered into a new employment agreement with the Chairman for a period of five years. Under the terms of this agreement, the Chairman has been retained to provide certain management services to the Company and its subsidiaries. The Company has agreed to issue, under the Agreement, a number of fully paid and non-assessable common shares of the Company equal to 0.5% per quarter of the number of common shares outstanding on the last day of March, June, September and December of each year throughout the term of the agreement. An amount of $1,431,545 had been accrued for the value of shares, that had been earned but not issued as compensation expense for the year ended October 31, 2001 and treated as contributed surplus within shareholders’ equity. On March 26, 2002, the Company issued 765,589 shares relating to compensation for the period ended October 31, 2001, valued at $1,431,545.
MICROMEM TECHNOLOGIES INC.
(A DEVELOPMENT STAGE COMPANY)
Notes to Consolidated Financial Statements
(Expressed in United States dollars)
October 31, 2002
|
13. Management compensation and related party transactions (continued):
(iii)
On January 2, 2000, the Company entered into an Employee and Option Agreement with the Chairman of Micromem which was approved by the shareholders at a meeting held on June 29, 2000.
As remuneration for the services to be rendered by the Chairman during the period from January 2, 2000 to January 2, 2001, the Company granted the Chairman an irrevocable option to acquire from the Company a number of fully paid and non-assessable common shares of the Company equal to 1.75% of the number of common shares of the Company that will be outstanding on the close of business on January 2, 2001, at a price of $0.10 per incentive share.
Pursuant to this agreement, deferred share compensation for the Chairman for the period from January 2, 2000 to January 2, 2001 in the amount of $2,711,881, representing an estimate of the intrinsic value of the options to be granted on January 2, 2001, was recorded as contributed surplus within shareholders’ equity. Of this amount, $2,258,592 was recorded as compensation expense in the year ended October 31, 2000. On January 17, 2001, the Chairman exercised his options and 714,686 common shares of the Company were issued with an aggregate value of $1,581,242, which was recorded as share capital. The difference between the actual value of the shares and the estimate recorded in 2000, of $677,420 was recorded as a recovery of compensation expense in the year ended October 31, 2001.
(iv)
On January 29, 1999 and March 10, 1999, the Company entered into two consulting agreements with the Chairman and a company controlled by the former President, respectively. Consideration for services rendered by the Chairman and the former President were settled by issue of common shares. The Company issued 454,292 shares to the Chairman and 448,452 shares to a company controlled by the former President during fiscal 2000. The balance of 11,192 shares ($66,461) due to a company controlled by the former President were issued in fiscal 2001.
[b] In the normal course of business, the Company enters into transactions with companies under common control. Such items are measured at agreed upon exchange amounts and included in the consolidated financial statements. During fiscal 2000, The Company paid $186,000 to legal firms in which directors of subsidiaries are partners.
MICROMEM TECHNOLOGIES INC.
(A DEVELOPMENT STAGE COMPANY)
Notes to Consolidated Financial Statements
(Expressed in United States dollars)
October 31, 2002
|
14. Commitments:
(a) Research Collaboration Agreement
On October 24, 2002, Micromem entered into a two year Research Collaboration Agreement with Materials and Manufacturing Ontario (“MMO”), a not-for-profit organization funded by the provincial government, University of Toronto (“U of T”) and a Researcher employed by the U of T, to fund the research on Magnetic Structure development for Hall effect memory devices.
Under the terms of the agreement, the Company has committed to contribute $87,432 (Cdn.$136,000) and $18,000 (Cdn.$28,000) in cash and in-kind contribution, respectively, per year to fund the research. As at October 31, 2002, the Company has contributed $87,432 in cash against this commitment which has been included in deposits and other receivables as at year end.
In addition, Micromem will have sublicensing rights for the use of any new technology developed (“Technology Developed”) under this research with an annual royalty payable in perpetuity to MMO based on a percentage of revenues from the sale of products incorporating the Technology Developed.
(b) Technology development agreement
On March 14, 2001, the Company’s subsidiary, Pageant, entered into a three year Technology Development agreement with Estancia and Lienau to continue the development of the MAGRAM Technology. Under the terms of the agreement, Pageant has committed to pay Estancia $215,000 per year, payable on a monthly basis in arrears, and committed to incur expenditures in connection with the MAGRAM development expenses of up to a maximum of $500,000 per agreement year.
On April 23, 2002, the Technology Development agreement was amended to extend its term for an additional 8-month period and to reduce the amount payable to Estancia under this agreement to $107,000 per year, payable monthly in arrears for the period commencing on June 1, 2002 through December 31, 2002 and for the extended period from March 9, 2004 through to November 9, 2004.
MICROMEM TECHNOLOGIES INC.
(A DEVELOPMENT STAGE COMPANY)
Notes to Consolidated Financial Statements
(Expressed in United States dollars)
October 31, 2002
|
(c) Operating leases
The Company has operating lease commitments which expire in 2006, in respect of its head office. The future minimum annual lease payments are approximately as follows:
2003
$
93,500
2004
93,500
2005
93,500
2006
15,500
296,000
15. Contingencies:
Pageant Technologies (U.S.A.) Inc. has been named as a defendant in legal actions relating to tenant improvements on a leased property, including an action claiming dues of approximately $880,000 alleging breach of contract under a construction contract entered into by Clear Blue Laboratories, Inc. [“Clear Blue”]. The landlord of the property is also claiming damages from Pageant Technologies (U.S.A.) Inc. Pageant Technologies (U.S.A.) Inc. assigned its rights under the lease to Clear Blue, however Pageant Technologies (U.S.A.) Inc. is allegedly obligated to pay the lease payments should the assignee default under the contract. The landlord is claiming damages of approximately $887,000.
The outcome of these actions is uncertain and Pageant Technologies (U.S.A.) Inc. is vigorously defending all actions in which it is named as a defendant. It is, therefore, not possible to provide an estimate of the financial effects, if any, of the actions. No losses related to these actions have been accrued in these consolidated financial statements. It is possible that the outcome of these claims could represent a material amount.
In the normal course of business, the Company and its subsidiaries are involved in various legal actions. In management's opinion, the ultimate disposition of these actions, individually or in aggregate, will not have a material adverse effect on the financial condition of the Company.
MICROMEM TECHNOLOGIES INC.
(A DEVELOPMENT STAGE COMPANY)
Notes to Consolidated Financial Statements
(Expressed in United States dollars)
October 31, 2002
|
16. Financial instruments:
(a) Fair values
The fair values for all financial assets and liabilities are considered to approximate their carrying values due to their short-term nature.
(b) Foreign items
The financial statements include balances/transactions that are denominated in foreign currencies as follows:
Canadian Dollar
Euro
Assets
$
172,356
€
111,201
Liabilities
59,233
97,972
Income
–
792
Expenses
1,109,510
122,203
17. Reconciliation between Canadian GAAP and U.S. GAAP:
The Company's consolidated financial statements have been prepared in accordance with Canadian GAAP which, in the case of the Company, conform in all material respects with U.S. GAAP, except as follows:
(a) Stock based compensation:
The Company has chosen to account for employee stock-based compensation using the intrinsic value method prescribed in Accounting Principles Board Opinion ("APB") No. 25, Accounting for Stock Issued to Employees. Under this method, compensation expense is recorded if the market value exceeds the exercise price at the date of grant. The compensation expense, if any, is recognized, at the date of option grants or when the option shares are earned when future performance is required, in the consolidated statements of operations and deficit.
MICROMEM TECHNOLOGIES INC.
(A DEVELOPMENT STAGE COMPANY)
Notes to Consolidated Financial Statements
(Expressed in United States dollars)
October 31, 2002
|
17. Reconciliation between Canadian GAAP and U.S. GAAP (continued):
For the purposes of reporting under U.S. GAAP, companies are required under SFAS 123 to calculate and disclose on a pro forma basis, the compensation expense related to the fair value of the stock options granted during the year in the notes to the consolidated financial statements. Accordingly, for the purpose of reporting under U.S. GAAP, the Company's net loss applicable to common shares and loss per common share would be increased to the pro forma amounts as follows:
Period from
September 3,
1997 to
October 31,
2002
2001
2000
2002
Loss applicable to
common shares:
Reported
$
12,733,015
$
4,559,625
$
7,259,356
$
Pro forma
14,565,515
9,187,377
14,640,604
46,402,284
Basic and fully diluted
loss per share:
Reported
$
0.27
$
0.10
$
0.19
$
0.65
Pro forma
0.31
0.21
0.38
1.00
There were no options granted during 2002. The fair values of all options granted during 2001 and 2000 were estimated as of the date of grant using the black-Scholes option pricing model with the following assumptions:
2002
2001
2000
Dividend yield
–
–%
–%
Expected volatility
–
100%
100%
Risk-free interest rate
–
3.97% - 5.52%
4.87% - 6.36%
Expected option life
–
2 - 3 years
1 - 4 years
The effects of the pro forma disclosures are not likely to be representative of the effects on reported net income for future years, because options vest over several years and additional awards may be made in future years.
MICROMEM TECHNOLOGIES INC.
(A DEVELOPMENT STAGE COMPANY)
Notes to Consolidated Financial Statements
(Expressed in United States dollars)
October 31, 2002
|
(b) Statement of comprehensive income (loss):
Comprehensive income (loss) includes all changes in equity during the periods presented except shareholder transactions. For the periods presented, accumulated other comprehensive loss comprises the Company's change in unrealized gain on investment.
For the purpose of reporting under U.S. GAAP the components of comprehensive income and total comprehensive income are reported in the statement of changes in shareholders equity, below the net loss in the statement of operations and in a separate statement of comprehensive income as follows:
Period from
September 3,
1997 to
October 31,
2002
2001
2000
2002
Net loss
$
12,733,015
$
4,559,625
$
7,259,356
30,260,775
Change in unrealized
gain on investment
–
–
(13,796
)
(13,796
)
Comprehensive loss
$
12,733,015
$
4,559,625
$
7,245,560
$
30,246,979
As the investment was classified as available-for-sale, the unrealized gain was treated as part of the statement of comprehensive income.
MICROMEM TECHNOLOGIES INC.
(A DEVELOPMENT STAGE COMPANY)
Notes to Consolidated Financial Statements
(Expressed in United States dollars)
October 31, 2002
|
18. Subsequent event:
On November 1, 2002 [“effective date”], Micromem has entered into an Infrastructure Agreement with the U of T, to fund the assembly of a facility for research and development and fabrication of Magnetic Memory (“MMF”). The U of T has agreed to use the MMF in connection with, among other things, research to be conducted pursuant to collaborations between Micromem and the U of T.
Under the terms of the agreement, Micromem has committed to contribute $231,140 (Cdn.$360,000) in cash to fund the direct costs of MMF. The sum is payable to U of T as follows:
[i] |
$77,047 (Cdn. $120,000) on execution of agreement, which was paid on November 28, 2002; | |
|
||
[ii] |
$77,047 (Cdn. $120,000) at end of the two months following the effective date; and | |
[iii] |
$77,047 (Cdn. $120,000) at end of the four months following the effective date. |
ITEM 18 FINANCIAL STATEMENTS
Not Applicable
ITEM 19. EXHIBITS
The following exhibits are filed as part of this registration statement and attached hereto:
SIGNATURES
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant certifies that it meets all of the requirements for filing on Form 20-F and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized.
MICROMEM TECHNOLOGIES INC.
By: "Joseph Fuda" (signed)
Name: Joseph Fuda
Title: Chief Executive Officer
By: "Antonio Lopes" (signed)
Name: Antonio Lopes
Title: Chief Financial Officer
Dated: March 20, 2003.
[1] VEMRAMä is a trade-mark of Memtech International Inc., a Bahamas corporation wholly-owned by Micromem, and is used under license by Micromem and other corporations affiliated with Micromem.
[2] HEMRAMä is a trade-mark of Memtech International Inc., a Bahamas corporation wholly-owned by Micromem, used under license by Micromem and other corporations affiliated with Micromem.
Exhibit 9
This INFRASTRUCTURE AGREEMENT made in two original counterparts effective the 1st day of November 2002 (the "Effective Date").
BETWEEN:
MICROMEM TECHNOLOGIES INC.
(hereinafter called "Micromem")
- and -
THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO
(hereinafter called the "University")
WHEREAS the University has expertise in the area of magnetic material design and processing and intends to submit a proposal to the Canada Foundation for Innovation (the "CFI Proposal") for infrastructure support to facilitate its research in this area;
AND WHEREAS Micromem is engaged in the development of magnetic memory technologies and has agreed to be the corporate partner named in the CFI Proposal and to contribute towards the cost of the infrastructure;
Micromem and the University hereby agree as follows:
1. |
Magnetic Memory Facility. With the financial support to be provided by Micromem under this Agreement, the University will assemble a facility for the research and development and fabrication of magnetic memory ("MMF") as generally described in Appendix "A" attached hereto. | |||
2. |
Principal Investigator. The investigator responsible for the arrangements involved in acquisition and installation of the MMF shall be Professor Harry E. Ruda, of the University's Department of Materials Science and Engineering (the "Principal Investigator"). | |||
3. |
Grant. Micromem hereby grants to the University the amount of $360,000 as a contribution towards the direct costs of the MMF. Within ninety days following the assembly of the MMF, the University will provide Micromem with a financial statement confirming the University's application of the grant funding under this Agreement. | |||
4. |
Payment. The sum set out in Paragraph 3 above shall be paid by Micromem by cheque, payable to the University of Toronto, in installments, as follows: | |||
$120,000 on execution of this Agreement | ||||
$120,000 at end of two months following the effective date | ||||
$120,000 at end of four months following the effective date | ||||
5. |
Equipment. The University will own the MMF and any other equipment or material purchased by or provided to the University hereunder. The University will use the MMF, on a non-exclusive basis, for conducting magnetic memory research and development under existing and future collaboration arrangements between the University and Micromem, and additionally for other research and educational purposes as it may deem appropriate and necessary from time to time. | |||
6. |
Intellectual Property. Neither party shall acquire any right or license to any intellectual property now or hereafter owned or developed by the other party by virtue of this Agreement. | |||
7. |
Limitation of Liability. The University shall not be liable for any delays in the performance of its obligations under this Agreement resulting from circumstances or causes beyond the University's control and in no case shall the University be liable for loss of business or profit or other indirect or consequential damage. | |||
8. |
Term and Termination. This Agreement will enter into force as of the Effective Date and will terminate on the date of the final payment received by the University from Micromem, as per the schedule outlined in Paragraph 3. | |||
9. |
Survival. The provisions of Paragraphs 5, 6, 7, 9 and 10 shall survive termination or expiration of this Agreement. | |||
10. |
No Use of Names. Neither party will use the name of the other party, or of any member of the other party's personnel, in any advertising or publicity without the prior written approval of the other party's authorized representative. However, both parties may make Micromem' s support under this Agreement a matter of public record. | |||
11. |
Notices. Notices under this Agreement will be sent to the parties as follows: | |||
(a) |
to the University: | |||
i. |
for technical and scientific matters: | |||
Professor Harry Ruda
Department of Materials Science and Engineering and Energenius Centre for Advanced Nanotechnology University of Toronto, 170 College Street Toronto, Ontario M5S 3E4 Tel. (416) 978-4556 / Fax (416) 978-3801 |
||||
ii. |
for legal and administrative matters: | |||
Dr. Peter B. Munsche
Assistant Vice-President, Technology Transfer University of Toronto, Research Services 27 King's College Circle Toronto, Ontario M55 1A1 Tel. (416) 978-6063 / Fax (416) 978-5821 |
||||
(b) |
to Micromem: | |||
i. |
for all matters: | |||
Manoj Pundit
Executive Vice-President and General Counsel Micromem Technologies Inc. 777 Bay Street, Suite 1910 Toronto, Ontario M5G-2E4 Tel: (416) 364-6513 x222 /Fax: (416) 360-4034 |
12. |
Independent Parties. The parties are independent parties and nothing in this Agreement shall constitute either party as the employer, principal or partner of or joint venturer with the other party. Neither party has any authority to assume or create any obligation or liability, either express or implied, on behalf of the other. |
13. |
No Assignment. Neither party may sell, assign, encumber, license or otherwise transfer any of its rights, duties or obligations under this Agreement without the prior written consent of the other party, which consent may not be unreasonably withheld. |
14. |
Successors. This Agreement shall bind and ensure to the benefit of the parties and their respective heirs, successors and permitted assigns. |
15. |
Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the Province of Ontario and the laws of Canada applicable therein. |
16. |
Paragraph Headings. Paragraph headings are provided for convenience and shall not be used to construe this Agreement. |
17. |
Entire Agreement. This Agreement, including any appendices attached hereto, is the entire agreement between the parties on the subject matter hereof. No modification of this Agreement will be binding upon the parties unless it is in writing and signed by the parties. |
In witness whereof the parties agree to be bound by the terms of this Agreement.
MICROMEM TECHNOLOGIES INC. |
THE GOVERNING COUNCIL OF
THE UNIVERSITY OF TORONTO |
|
"signed"
|
"signed"
|
|
Name: Joseph Fuda | Name: Peter B. Munsche | |
Title: President and Chief Executive Officer |
Title: Assistant Vice-President,
Technology Transfer |
Acknowledgement:
I, the Principal Investigator, having read this Agreement, hereby agree to act in accordance with all the terms and conditions herein and applicable University policies, and further agree to ensure that all University participants are informed of their obligations under such terms and conditions.
"signed"
Harry E. Ruda
Principal Investigator
APPENDIX "A"
MAGNETIC MEMORY FACILITY
The new Magnetic Memory Facility (MMF) will constitute a state of the art facility with processing capabilities which will enable a variety of magnetic memory structures to be deposited and lithographically patterned. Assembly of the MMF will include:
Oxynitride PEC VD/RIE Systems:
The system is a Dual Chambered RIE/PECVD system on one table-top chassis capable of depositing silicon oxide and silicone nitride in the first chamber and performs reactive ion etching in the second. The system will include a 13.56Mhz 500watt RF Generator capable of pulse mode and bias control, a matching network, a pressure controller, a temperature controller and an industrial touch screen computer for system control. This system can be upgraded in the future to have more features.
Scrubber (and gas Handling):
The system is a wet scrubber able to abate process by-products as well as reactor feed gases. The scrubber works in a totally recirculating mode. An alkaline chemical solution can be utilized to maximize scrubbing efficiency.
Electrochemical deposition system:
This electroplating system comprises a polypropylene cell containing an electrolyte (solution) with platinum electrodes with immerged sample holders, a potentiostat/galvanostat to control the current and the potential between the electrodes, a current source to drive the chemical process, and a computer system with IEEE card and software (Electrochemistry Pack) to control and monitor the process. The system serves as an electroplating system for seed and magnetic material deposition, and can be upgraded for photo-assisted electrochemical etching.
Plasma Asher:
The system is a plasma reactor, used for surface treatment and fast stripper of photoresist from substrates.
Clean Room Kit/Wet Bench:
The system is an acrylic clean room of about 25 meter square with class 100 and 1,000 sections allowing researchers to work in a clean environment. It includes equipment and accessories such as an air shower, wet bench, pass through, air conditioners, dehumidification and RH control, vacuum and gas connections.
DI water:
The system provides grade I quality water quality compatible with an Integrated Circuit processing environment.
Installation and initial set-up costs (electrical, plumbing, gas service):
This includes all the electrical and plumbing services, as well as gas supply and handling, required for the new equipment to be installed, and used for etching, deposition and cleaning process.
Exhibit 3
For Ministry Use Only
|
Ontario Corporation Number
|
1. |
|
641943
|
TRANS CODE |
C |
18 |
Exhibit 5
BY-LAW NO. 1A
OF
MICROMEM TECHNOLOGIES INC.
A BY-LAW TO AMEND SECTION 29 OF BY-LAW NO. 1 OF THE
CORPORATION RESPECTING THE REQUIREMENT FOR THE
PRESIDENT TO BE APPOINTED FROM AMONGST
BE IT ENACTED and it is hereby enacted as a by-law of Micromem Technologies Inc. (hereinafter, the "Corporation") as follows:
Section 29 of By-Law No. 1 of the Corporation entitled, "A By-Law Relating Generally to the Transaction of the Business and Affairs of Mine Lake Minerals Inc.", is hereby amended such that the following sentence:
"The President shall be appointed from amongst the directors."
is hereby removed in its entirety and replaced with the following sentence:
"The President may be but shall not be required to be appointed from amongst the directors."
PASSED the 30 th day of June, 1999.
/s/ Sam Fuda
|
|
Name: Sam Fuda | |
Title: Chairman and Secretary |
Exhibit 6
-1-
RESEARCH
COLLABORATION AGREEMENT
This Agreement made as of the 24th day of October, 2002 among:
MATERIALS AND MANUFACTURING ONTARIO
(herein called "MMO")
- and -
MICROMEM TECHNOLOGIES INC.
(herein called "Industry Participant")
- and -
THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO
(herein called "University")
- and -
Dr. Harry Ruda
(herein called the "Researcher")
WHEREAS the Researcher is employed by the University as a professor and principal investigator and is entitled to participate in research projects funded in whole or in part by MMO in accordance with the terms of the University Collaboration Agreement between MMO and the University effective as of January 1, 1998, (the University Collaboration Agreement).
AND WHEREAS the Researcher has prepared and submitted a project proposal entitled "Magnetic structure development for Hall-effect Memory Devices" (MMO Project #EE40066) attached as Appendix A involving contribution by all of the parties (the "Proposal");
AND WHEREAS the parties have agreed to proceed with the Proposal and wish to set out their respective rights and obligations with respect thereto;
LIAISON PERSONNEL
MMO LIAISON: | Dr. Bradley Fox |
INDUSTRY PARTICIPANT LIAISON: | Mr. Manoj Pundit |
PROJECT LEADER: | Dr. Harry Ruda |
-2-
NOW THEREFORE for valuable consideration the parties agree as follows:
For the purpose of this Agreement:
(a) "Technology" shall mean any technology, invention, formula, method, development, computer software (including source code and all related documentation), process, know how, pattern, machine, device manufacture, composition of material, compilation of information, data, database or any improvement thereof, and including all related intellectual property rights such as patents, copyrights, trade secrets, trade-marks and other proprietary rights, which was, in whole or in part, conceived or reduced to practice using funds provided by MMO under this Agreement. In those cases where Industry participants are involved or there are pre-existing rights, only that portion of the intellectual property supported by funds contributed by the MMO will be Technology.
(b) "Proposal" means the final written project proposal dated May 20, 2002 and submitted to MMO by the Researcher with respect to the project entitled "Magnetic structure development for Hall-effect Memory Devices" (MMO Project #EE40066) including schedules thereto, all as may be amended from time to time by agreement of the parties hereto;
(c) "Project" means the project outlined in, and to be undertaken pursuant to, the Proposal;
(d) "Net Revenue" means gross revenues received by MMO from sublicensing the Technology less all costs of sublicensing, including, but not limited to:
(ii) fabrication of prototypes and production of samples;
(iii) identifying sublicensees and negotiating sublicense agreements including the legal costs associated therewith.
(e) "Confidential Information" shall mean the confidential business or technical information of a party hereto that is identified as such in writing at the time of its disclosure or identified orally at the time of its disclosure, minuted and confirmed in writing within two weeks of the oral identification.
The provisions of the University Collaboration Agreement, to the extent the same do not conflict with the provisions of this agreement, shall apply to the Project and bind the Researcher, the University and MMO in respect thereof in accordance with its terms. In the event of a conflict between the provisions of the University Collaboration Agreement or Proposal and the provisions of this Agreement, the provisions of this Agreement shall prevail to the extent of such conflict.
-3-
PART A - THE PROJECT
Al. Each of the parties hereto accepts the Proposal and subject to the terms and conditions hereof agrees to participate in the Project as contemplated by the terms of the Proposal. Payment to the University will be made through MMO accounts set up at the University. Payments will be made in the same manner as payments are made for all other MMO accounts.
A2. The contributions of the respective parties to the Project shall be in accordance with the Proposal, except that the cash contribution by the Industry Participant shall be as specified in paragraph two of this clause. Continued funding by MMO pursuant to the Proposal is conditional on satisfactory progress with respect to the milestones, as determined by MMO. Continued funding by Micromem pursuant to the Proposal is conditional on satisfactory progress with respect to the milestones, as determined by Micromem and the Researcher. The parties agree to provide such records and other assurances as may be reasonably requested by any party hereto as evidence of their respective contributions.
Industry Participants cash contribution, + 7% G.S.T ., will be payable to MMO in installments in advance, against invoices provided by MMO. Of the total amount of $272,350, $136,175 + 7% G.S.T. will be billed to Industry Participant once the contract has been signed by all parties and issued and will be payable within 30 days of receipt by Micromem. The balance as follows: an invoice for $136,175 + 7% G.S.T. to be issued on the one-year anniversary date of the execution of this Research Collaboration Agreement and will be payable within 30 days of receipt by Micromem.
A3. In addition to the contributions of the parties outlined in the Proposal, during the term of the Project MMO shall provide ongoing project management services including an annual review of the progress with respect to the agreed upon milestones.
A4. Each of the parties agree to co-operate with respect to the successful completion of the Project provided that in the event any of the parties fails to comply with its contribution obligations outlined in paragraph A2 above and such failure is not remedied within forty-five (45) days after a request to do so has been made, in addition to any other rights or remedies that may be available at law or in equity, the other parties or either of them may withdraw from the Project and their obligations with respect thereto. In no event shall a party be liable for damages if the Project results are not successful or commercially useful provided they have acted in good faith and with due diligence in the performance of their obligations under the Proposal.
A5. Notwithstanding paragraph A4 above, in the event that at any time during the currency of the Project Ontario government funding to MMO is at any time suspended, revoked or terminated and MMO is then unable to provide the contributions contemplated hereby, MMO shall be released from its obligations hereunder and shall not be liable for any damages arising therefrom, provided however that the University will be compensated for appropriate costs incurred and commitments made hereunder to the date of such suspension, revocation or termination.
A6. The Project Leader will provide a final report of this Collaborative Project to MMO and to Industry Participant within 60 days after the completion of the project as described above, or as modified for reasons of delays beyond the control of the University, but as restated.
A7. Subject to clauses A3 and A4 above, the duration of the Project shall be 24 months.
-4-
PART B - OWNERSHIP IN THE TECHNOLOGY
B1. Researcher warrants that he is and will continue to be the project leader and a potential inventor of the Technology. Researcher agrees to ensure that every participant and potential inventor in the Project shall execute and deliver to MMO an acknowledgement in the form attached as Schedule "A". Ownership in the Technology shall be dealt with in accordance with the University Inventions Policy and the University Collaboration Agreement.
B2. Researcher and/or the University covenant and agree to indemnify MMO and/or the Industry Participant from and against any claims, demands, liability, costs or expenses which either of them may suffer or incur arising from, out of or in connection with controversy or dispute among the participants in the Project with respect to the issue of inventorship or ownership of the Technology.
B3. The parties jointly and severally agree to co-operate fully with a view to the commercial exploitation of the results from the Project, which shall include the following obligations to be performed as required (without reimbursement or remuneration):
(i) maintaining complete and accurate records detailing the stages, procedures and persons involved in the Project and make such records available to MMO upon request;
(ii) providing to MMO full and true disclosure of all aspects of and particulars relating to the Project;
(iii) responding to reasonable requests from MMO for further clarification or particulars relating to the Project;
(iv) executing and delivering all documents or other assurances as may be necessary to file and prosecute letters patent or other intellectual property rights relating to the Project and assisting if necessary with any written or verbal responses or presentations related thereto;
(v) providing reasonable assistance to MMO to support MMO's commercialization activities for the Technology.
B4. University and Researcher hereby grant to MMO the exclusive right to obtain a world-wide exclusive license to grant sublicenses of the Technology. In consideration for such license, MMO agrees to pay to the University, for and on behalf of all inventors and owners of the Technology, **** of all Net Revenue received by MMO in connection with the sublicense of such Technology. This grant and license applies to all applications of the Technology and any Improvements thereto. Any arrangements for revenue sharing between the Researcher, the University and/or any other inventors or owners shall be made directly between such parties. The University and the Researcher reserve the right to use the Technology for research and educational purposes subject to paragraph B5.
_______________________________________________
*Material contained at this place in the document has
been omitted pursuant to a request for confidential treatment and such
material has been separately filed with the Securities and Exchange
Commission.
-5-
B5. (a) The purpose of the Project is to foster university-industry collaboration and to promote research for the creation of new knowledge. Accordingly, the parties accept and agree that it is their mutual interest and intention to publish and disseminate the results of the Project in the scientific literature and at scientific conferences as part of their joint interests to contribute to knowledge in the field. The parties accept that there will not be any restriction to such publication or disclosure and affirms that there shall not be any restriction on the publication of any thesis prepared and submitted by any graduate student in partial fulfillment of University degree requirements or other communications submitted for the purpose of academic evaluation of the graduate student or Researcher.
(b) The Researcher will give written notice to MMO, the Industry Participant and the University at least thirty (30) working days in advance of any public disclosure of research or development results, data or technical information relating to the Technology, to provide MMO and the Industry Participant with the opportunity to review the results of the Project for potential business benefits or commercialization and to ensure that Confidential Information has not been included. MMO and the Industry Participant shall have twenty (20) working days from receipt of the notice to respond to the University. The failure of either MMO or the Industry Participant to respond shall be deemed to be its respective approval of the disclosure. If MMO elects to file for protection of the Technology, the Researcher will delay publication or disclosure for a period of sixty (60) days from the receipt of MMO's written request. Subject to the foregoing, the Participant may publish and disclose the Technology and research results arising from the performance of the Project and shall acknowledge the support of MMO and the Industry Participant in all such publications.
PART C - INDUSTRY PARTICIPANT RIGHTS
Cl. Provided that the Industry Participant is in compliance with the provisions of this Agreement, the Industry Participant shall have the first right to an exclusive, world-wide and perpetual sub-license ("Sub-License") for the use of any Technology with a Royalty ("Royalty) payable to MMO as set forth in sections C2 and C3 below. The Industry Participant must exercise such right within **** months of the completion of the Project by notice in writing to the other parties. The parties shall finalize and execute an agreement in writing for the Sub-License within **** months of such notice on the terms set forth in this agreement.
_______________________________________________
*Material contained at this place in the document has
been omitted pursuant to a request for confidential treatment and such
material has been separately filed with the Securities and Exchange
Commission.
C2. The Royalty shall constitute an annual royalty of: (i) ****% of those revenues ("Product Revenues") of the Industry Participant that are directly and specifically allocable to the sale of products incorporating the Technology by the Industry Participant; and (ii) a percentage to be negotiated, but which in no event shall exceed ****%, of those revenues ("Sub-license Revenues") of the Industry Participant that are directly and specifically allocable to the sub-license of the Technology by the Industry Participant (with consideration being given to costs incurred by the Industry Participant directly related to the sub-license or sub-licenses of the Technology). The Royalty rate shall decrease to ****% immediately when the aggregate of all royalties and license fees (including those described in section C3 below) paid to MMO by the Industry Participant in respect of any memory related technology funded by MMO equals $****. The Industry Participant's obligation to make any Royalty payments shall cease in
_______________________________________________
*Material contained at this place in the document has
been omitted pursuant to a request for confidential treatment and such
material has been separately filed with the Securities and Exchange
Commission.
-6-
respect of sales or sub-licenses entered into following the expiry of any patents issued in Canada or the United States in connection with the Technology.
C3. There will be no other fees or charges payable by the Industry Participant to any party in order to maintain the License in good standing in addition to the Royalty payments set forth in section C2 above, except that Industry Participant shall pay MMO a license fee of $**** at the end of each year commencing the **** year following execution of the License agreement. Industry Participant will receive credit toward the $**** license fee in respect of a year for: (i) any Royalty payments made in respect of the year, and (ii) any legal or other costs incurred during such year in protecting all intellectual property associated with the Technology to a maximum of $**** per year.
C4) Permitted uses of the Technology under the License shall consist of the use, development, design, manufacture, license, sub-license and sale of **** incorporating the Technology or any portion of the Technology exclusively throughout the world.
C5) For further clarity, it is agreed that nothing in this Agreement nor any document or agreement referenced in this Agreement conveys any rights or interests in Micromem's Background Technology from Micromem and/or its affiliates to the other parties to this Agreement, and that Technology shall exclude Micromem's Background Technology.
C6) In the event that, within **** days of completion of development of the Technology or any portion of the Technology that is patentable, MMO does not make an application for patent in respect of the same, Industry Participant shall have the exclusive right to file patent applications in respect of the same in such jurisdictions as it deems necessary. The Researcher and such other persons who are by law deemed to be inventors of the Technology shall be named as the inventor or inventors under any patent application in respect of the Technology. Upon request from one of Industry Participant and MMO to the other, the other party shall certify forthwith in writing whether a patent application has been or will be made for a particular Technology or portion of the Technology in each jurisdiction named in the request.
"Micromem's Background Technology" means any technology, invention, formula, method, development, computer software (including source code and all related documentation), process, know how, pattern, machine, device manufacture, composition of material, compilation of information, data, database or any improvement thereof, and including all related intellectual property rights such as patents, copyrights, trade secrets, trade-marks and other proprietary rights, which are, in whole or in part, conceived or reduced to practice by or on behalf of the Industry Participant and/or its subsidiaries and affiliates without using funds provided by MMO under this agreement.
PART D – GENERAL
Dl. (a) The parties may disclose Confidential Information one to another to facilitate work under this Agreement. Such information shall be safeguarded and only disclosed to persons with a need to know within the University, MMO and the Industry Participant. All parties shall
_______________________________________________
*Material contained at this place in the document has
been omitted pursuant to a request for confidential treatment and such
material has been separately filed with the Securities and Exchange
Commission.
-7-
use their best efforts to protect such information from disclosure to third parties not bound by relevant nondisclosure agreements.
(b) The obligation to keep confidential shall however not apply to information which:
(i) is already known to a third party to whom it
is disclosed;
(ii) becomes part of the public domain without
breach of this Agreement;
(iii) is obtained from third parties which have
no confidentiality obligations to the contracting parties; or,
(iv) is authorized for release by the disclosing
party.
(c) Each party shall take all proper measures, and at least the same measures as it takes in respect of its own Confidential Information, to keep confidential the Confidential Information provided to it by another party. No party shall use another party's Confidential Information for any purpose except that for which it was initially provided to the party. The University shall have all persons involved with the Project sign research participant agreements in the form attached as Schedule "A".
(d) Each party hereto accepts and agrees that this term of confidentiality shall persist for a period of five (5) years after the completion or termination of this Agreement. Upon completion or termination of this Agreement, each party that has received confidential information or material during the course of the Agreement shall, upon written request, return such confidential information and material to the other and shall not retain copies or transcripts thereof for any purpose whatsoever.
D2. The failure of either party to exercise their rights herein upon the occurrence of any breach by the other party of its obligations shall not in any event constitute a waiver of such rights if any such breach by the other party should reoccur.
D3. This Agreement and all its rights and privileges hereunder may not be assigned by any party without the prior written consent of the others. This Agreement and everything herein contained shall inure to the benefit of and be binding upon each of the parties hereto and upon their respective successors and permitted assigns.
D4. This Agreement shall be construed in accordance with the laws of the Province of Ontario.
D5. (a) The parties shall use their best efforts to settle in a fair and reasonable manner any financial or business dispute arising in connection with this Agreement. If such dispute cannot be settled by the parties between themselves, it shall be first submitted to mediation by a mediator chosen jointly by the parties.
(b) In the event that mediation does not bring a resolution of the dispute within thirty (30) days, the dispute shall be submitted to arbitration before a single arbitrator pursuant to the Arbitration Act of Ontario and the schedules thereto (as amended from time to time). Any such arbitration will be subject to the rules set forth in Schedule "E" of the University Collaboration Agreement.
D6. In no event shall any of the parties hereto be liable to each other for any indirect, special or consequential damages, including loss of profit, arising from or in connection with the breach,
-8-
non-performance or termination of this Agreement or any of the rights or obligations arising hereunder.
D7. The parties are not and shall not be considered to be joint venturers, partners or agents of
each other and neither of them shall have the power to bind or obligate the other except as set forth in this Agreement. The parties mutually covenant and agree that neither shall they, in any way, incur any contractual or other obligation in the name of the other, nor shall they have liability for any debts incurred by the other.
D8. All notices, demands or other communications required to be made or given pursuant to the terms of this Agreement shall be in writing and shall be delivered personally, by courier or by prepaid first class post, to the parties at their respective addresses as hereinafter set out, or such other addresses as the parties may subsequently advise in writing. Any notice, demand or other communication mailed shall be deemed to be received either:
(i) if mailed, then on the fifth (5th) day of
business next following that date of mailing;
(ii) if delivered personally, then on the actual day
of delivery; or
(iii) if delivered by courier, then on the second
(2nd) day of business next following the date the same was delivered by
the sender to the courier.
In the event that the postal services shall be disrupted due to strike, lockout or otherwise, all notices, demands or other communication shall be delivered personally or by courier. The following shall be the addresses for the delivery of notices to each of the parties:
(a)MMO: |
Materials and Manufacturing Ontario |
|
2655 North Sheridan Way |
|
Suite 250 |
|
Mississauga, Ontario |
|
L5K 2P8 |
|
Attention: Mr. J.G. Clarke |
|
President & CEO |
(b) Industry Participant: |
Micromem Technologies Inc. |
|
777 Bay Street, Suite 1910 |
|
Toronto, Ontario |
|
M5G 2E4 |
|
Attention: Mr. Manoj Pundit |
|
Executive Vice President |
-9-
(c) University: |
University of Toronto |
|
Research Services |
|
27 King's College Circle |
|
Toronto, Ontario |
|
M5S 1A1 |
|
|
|
Attention: Ms. Jennifer Maclnnis |
|
Contracts Officer |
(d) Researcher: |
Dr. Harry Ruda |
|
Energenius Chair in Advanced Nanotechnology |
|
Dept. of Metallurgy & Materials Science |
|
University of Toronto |
|
Wallberg Building, Room 3 |
|
184 College Street |
|
Toronto, Ontario |
|
M5S 1A4 |
or to such other address as the addressee may have specified in prior written notice to the addressor.
IN WITNESS WHEREOF the parties hereto have executed this Agreement.
For University:
Oct.22, 2002
|
"signed"
|
Assistant Vice-President
|
||
(date) | (signature) | (title) |
For Materials and Manufacturing Ontario:
Oct.24, 2002
|
"signed"
|
J.G. Clarke
President & C.E.O. |
||
(date) | (signature) | (title) |
-10-
For Industry Participant:
Oct.21, 2002
|
"signed"
|
Joseph Fuda
C.E.O. |
||
(date) | (signature) | (title) |
For Project Leader:
ACKNOWLEDGEMENT:
I, the project leader, having read this Agreement, hereby agree to act in accordance with all the terms and conditions herein and further agree to ensure that all university participants are informed of their obligations under such terms and conditions.
Oct. 22, 2002
|
"signed"
|
(date) | (signature |
-11-
Schedule "A"
RESEARCH PARTICIPANT AGREEMENT
THIS AGREEMENT is made the 24th day of October, 2002 between Materials and Manufacturing Ontario (the "Centre"), the University of Toronto (the "University"), Dr. Harry Ruda (the "Project Leader") and __________________________________ (the "Participant(s)") with respect to the project entitled "Magnetic structure development for Hall-effect Memory Devices" (MMO Project #EE40066).
WHEREAS:
(a) the Centre and the University are parties to a University Collaboration Agreement dated January 1, 1998 (the "UC Agreement"), under which the Centre will provide funding to the University to carry out certain research projects ("University Projects"), while the Centre ensures the commercialization of the intellectual property emanating from such projects in collaboration with the University where appropriate;
(b) the Participant is associated with the University and will be involved in University Projects; and(c) it is a condition of the UC Agreement that the Participant signs this Agreement.
NOW THEREFORE, in consideration of the mutual promises set forth in this Agreement, the parties hereto agree as follows:
1. UNIVERSITY PROJECT
The research participant will, on a best efforts basis, strive to achieve the objectives and deliverables defined in the University Project proposal.
2. INTELLECTUAL PROPERTY
(a) Ownership. Centre Intellectual Property shall be owned by the Inventor(s), subject to any existing obligations to transfer assignable rights arising from the relevant policies of the University, and subject to the terms of this Agreement. If the Participant owns the Centre Intellectual Property, the Participant may assign the rights in Centre Intellectual Property to the Centre or the University upon the agreement between the Participant and the Centre if assigned to the Centre, and between the Participant and the University if assigned to the University. The Participant represents and warrants that he/she has notified in writing the University and the project leader for the University Project of any pre rights that would interfere with the commercialization of intellectual property arising from the University Project.
-12-
(b) Commercialization. Unless the Participant is otherwise notified in writing by the Centre, the Centre shall be responsible for ensuring the commercialization of the Centre Intellectual Property, in collaboration with the University where appropriate. To this end, the Centre shall have and the Participant hereby grants to the Centre the exclusive rights to obtain a world-wide, exclusive, royalty-free, fully paid-up license to make, use, reproduce, sell, modify and sub-license (with a right to further sub-license) Centre Intellectual Property. These rights shall be subject to a license agreement consisting of standard terms and negotiated special terms as outlined in Schedule "F" to the UC Agreement. This license shall be perpetual and irrevocable subject to the conditions as set out in Schedule "F" to the UC Agreement. The perpetual terms of the license may be withdrawn and the license revoked upon reasonable notice of the Owner(s) if the Centre fails to pursue commercialization of a particular Centre Intellectual Property within a reasonable time. The University shall retain the right to use such Centre Intellectual Property for research and educational purposes subject to agreements related to Confidential Information.
(c) Revenue Sharing. Except as otherwise provided for a particular University Project, Net Revenues derived from Centre Intellectual Property shall be divided as follows: one third to the Centre; and the remainder among the University and Inventors according to University policy.
(d) Termination. The Participant acknowledges and agrees that if the Centre ceases to carry on the research program related to the Centre Intellectual Property, or if the funding of the research program is terminated, the Government of Ontario shall have the first right (but not the obligation) to take an assignment of the rights and interest of the Centre in and to the Centre Intellectual Property.
(e) Disclosure; Patents. The Participant shall keep the Centre fully and promptly informed on an on-going basis of the development of Centre Intellectual Property, as well as of applications for intellectual property Protection (if any) filed in respect of Centre Intellectual Property. The Participant shall use the University invention disclosure form set out in Appendix Dl hereto. The Centre shall have the first right to file for intellectual property Protection on the Centre Intellectual Property. If, within three months after receipt of the relevant completed disclosure form, the Centre has not filed for intellectual property Protection, in respect of the Centre Intellectual Property, the University or the Inventor shall be entitled to do so.
(f) Confidentiality. The Participant shall take reasonable measures, and at least the same measures as it takes in respect of his/her own Confidential Information, to keep confidential the Confidential Information provided to it by the Centre or the University. The Participant shall not use the Confidential Information of the Centre or the University for any purpose except that for which it was initially provided to the party.
-13-
The obligation to keep confidential shall, however, not apply to information which:
(i) "Centre Intellectual Property" means any technology, invention, formula, method, development, computer software (including source code and all related documentation), process, know how, pattern, machine, device, manufacture, composition of material, compilation of information, data, database, or any improvement thereof, and including all related intellectual property rights such as patents, copyrights, trade secrets, trade-marks and other proprietary rights, which was, in whole or in part, conceived or reduced to practice using funds provided by the Centre under the UC Agreement.
(ii) "Confidential Information" means the confidential business or technical information of the Centre or the University that is identified as such in writing at the time of its disclosure or disclosed orally at the time of its disclosure, minuted and confirmed in writing within 2 weeks of the oral identification.
(iii) "Inventor" means the inventor, originator, creator, developer or author of Centre Intellectual Property.
(iv) "Net Revenues" means the revenue from royalties, license fees or other sources received by the Centre in respect of Centre Intellectual Property (or received by the University if there is a mutual agreement to have the University administer the Centre Intellectual Property) remaining after all out-of-pocket and arm's length expenses relating to the legal protection (including patenting and licensing costs) and the commercialization of such Centre Intellectual Property have been recovered and any payments with respect to obligations to third party sponsors have been made. For greater clarity, Net Revenues will include shares, securities or other ownership interests issued as consideration for the use or exploitation of Centre Intellectual Property.
-14-
3. PUBLICATION
(a) Pre-Disseinination Review. The Participant shall give written notice to the Centre and the University at least 30 days in advance of any public disclosure of research or development results, data or technical information relating to the Centre Intellectual Property (including any public defence of a thesis that contains relevant information or submission of the thesis or research results to external reviewers or anyone else outside of the University) in order to permit the Centre to exercise its rights under Section 2 (b) as well as to advise on the commercial value and/or patentability of the information disclosed. The Centre shall have 20 days from receipt of the notice to respond to the University; the Centre's failure to respond shall be deemed to be approval of the disclosure. If the Centre elects to file for protection of the Centre Intellectual Property, pursuant to sub-section 2(e) above, the Participant shall delay publication or disclosure for a period of 60 days from the receipt of the Centre's written request to enable the Centre to secure adequate protection of Centre Intellectual Property that would be affected by said publication or disclosure. Subject to the foregoing, the Participant may publish and disclose the Centre Intellectual Property and research results arising from the performance of University Projects and shall acknowledge the support of the Centre in all such publications.
(b) Theses. Nothing in this Agreement shall impose restrictions on the content or handling, for academic purposes, of theses of the Participant in a University Project. Nonetheless, the Centre may request, in writing, that the Participant delay publication or disclosure of a thesis for a period not to exceed one (1) year from the date of intended publication or disclosure, only if such publication or disclosure would prevent protection or commercialization of any Centre Intellectual Property or research results arising from performance of a University Project. The Centre may also request that a thesis defence be held in camera and that the members of the thesis examination board, including the external examiner(s), be required to sign a non-disclosure agreement. The Centre acknowledges that this Agreement does not obligate the Participant to delay publication or disclosure of a thesis.
4. GOVERNING LAW
This agreement shall be governed by and construed in accordance of the laws of the Province of Ontario.
THE PARTICIPANT ACKNOWLEDGES HAVING READ THIS AGREEMENT, UNDERSTANDING IT, HAVING HAD THE OPPORTUNITY TO OBTAIN INDEPENDENT LEGAL ADVICE IN RESPECT OF IT, AND AGREEING TO ITS TERMS. The Participant acknowledges having received a fully executed copy of this Agreement.
-15-
IN WITNESS WHEREOF the parties have executed this agreement as the day and year first above written.
Materials and Manufacturing Ontario | University of Toronto | |
By: | By: | |
Name: J.G. Clarke | Name: Peter B. Munsche | |
Title: President & CEO |
Title:
Assistant Vice-President
Technology Transfer, University of Toronto |
|
Witness | ) |
"signed" |
) |
Signature of Participant |
|
) | ||
) |
|
|
) | Signature of Participant (printed) | |
) | ||
Witness | ) |
|
) |
Signature of Participant |
|
) | ||
) |
|
|
) | Signature of Participant (printed) | |
) | ||
Witness | ) |
|
) |
Signature of Participant |
|
) | ||
) |
|
|
) | Signature of Participant (printed) | |
) | ||
Witness | ) |
|
) |
Signature of Participant |
|
) | ||
) |
|
|
) | Signature of Participant (printed) | |
) | ||
Witness | ) |
|
) |
Signature of Participant |
|
) | ||
) |
|
|
) | Signature of Participant (printed) | |
) | ||
Witness | ) |
|
) |
Signature of Participant |
|
) | ||
) |
|
|
) | Signature of Participant (printed) | |
Exhibit 2
For Ministry Use Only
|
Ontario Corporation Number
|
1. |
|
641943
|
TRANS CODE |
C |
18 |